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We encounter thousands of species of fungi each day, only a few of these are pathogenic to humans and 
even fewer are life threatening.  However, current fungal infection treatments come with a wide variety 
of issues. With some exhibiting high nephrotoxicity due to targeting issues, and others a lack of 
efficiency.  
Aptamers are short oligonucleotides, which exhibit affinity and specificity for a target molecule. These 
aptamers are determined through the process of SELEX. This is where target molecules, or in this case 
whole cells, are incubated with a pool of random aptamers. Non-binding aptamers are removed and 
binding aptamers are eluted and amplified by PCR. This enriches the pool with binding aptamers. This 
process continues as a cycle with each round of selection removing non-binding aptamers, and further 
amplifying the numbers of binding aptamers. Once rounds of selection are completed then the 
aptamers can be tested individually for their binding properties. Aptamers have already been found to 
be useful in industrial settings, with some aptamers even beginning to show in clinical settings.    
This study took whole cell A. fumigatus and C. albicans, in order to select aptamers that were specific to 
these cells without limiting the targets by incubating with individual target molecules. This study found 
isolated 11 aptamers with binding potential; these were then tested further to determine the binding 
capabilities, and their specificity. These aptamers were then isolated, sequenced and characterised to 
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There are estimated to be around 611,000 species of fungi on Earth, approximately 7% of all 
eukaryotic species (Mora et al., 2011). Of these around 600 species are human pathogens 
(Brown, Denning and Levitz, 2012), although a relatively small number, this group 
encompasses both those that cause mild infections and those that have the potential to cause 
life threatening infections.  Around 3 million people each year acquire an invasive fungal 
infection, with around 50% of these dying from the infection (Brown et al., 2012). The overall 
number of invasive fungal infections is on the rise with the increase in invasive medical 
interventions like haemopoietic stem cells transplants (Vazquez, Miceli and Alangaden, 2013) 
bringing with them an increased risk of infection. Also, the rise of immunosuppressive 
conditions like HIV/AIDS, where patients are especially vulnerable to fungal infections 
(Armstrong-James, Meintjes and Brown, 2014).   
1.2 Systemic Fungal Infections 
As with bacteria, most life threatening complications arise when microorganisms enter the 
tissue and bloodstream of a patient. Most healthy individuals have the immune capacity to 
prevent this from happening, however, patients with pre-existing conditions or patients who 
have undergone invasive surgical procedures are most at risk (Brown et al,. 2012). 
Mucosal Candidiasis is one of the early and most predominant infections in HIV infected 
patients (Greenspan and Greenspan, 1996).  Up to 90% of patients with HIV suffer from at 
least one case of oral candidiasis in their progression to AIDS. (Cassone and Cauda, 2012). This 
correlation is thought to be caused by the depletion of CD4 cells specific to Candida albicans, 
meaning that the immune systems no longer has the full capacity to control the spread of 
Candida (Nanteza et al., 2014). Other kinds of immunosuppression include conditions where 
the immune system neutrophil count is lowered, like with haemopoietic stem cell transplant or 
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certain kinds of chemotherapy, that can lead to cases of invasive Aspergillosis, as neutrophils 
play an important role in the control of Aspergillus species infection (Mircescu et al., 2009).  
A common risk of infection is patients that have undergone invasive treatments, for instance 
urinary catheterisation is a common cause of nosocomial infection especially in patients 
catheterised for a prolonged length of time. Urinary tract infections (UTI) caused by Candida 
species account for 10-15% of UTIs (Bukhary, 2008). 
 
1.3 Candida species 
Candida are a species of polymorphic fungi responsible for a wide range of cases of systemic 
fungal infections, referred to as Candidiasis. The most prevalent of these species is Candida 
albicans, which is responsible for the highest number of both invasive and superficial fungal 
infections. This opportunistic fungus lives commensally on the skin, the gastrointestinal tract 
and mucosal membranes of up to 75% of the population (White, 2004).  Public Health England 
(2018) reported 42% of cases of candidiasis as being caused by C. albicans, 24% being caused 




Table 1.1 (Public Health England, 2018) A summary of Candida spp. and the % of Candida 
infections they cause, in the UK from 2013 to 2017. 
 
The overall increase in infections since 2013 suggest that Candida species infections are a 
continuing threat. There are also a number of concerns regarding the development of drug 
resistant strains of these fungi. One of the fastest emerging species is Candida auris 
(Chowdhary, Sharma and Meis, 2017), with instances of this strain worldwide having increased 
over the past few years. This strain is commonly misdiagnosed as Candida haemulonii, their 
close phylogenetic relationship only being differentiated by sequence analysis of the D1/D2 
domain of the large ribosomal subunit of 26S rRNA gene and the internal transcribed spacer 
regions of the nuclear rRNA gene operon (Satoh et al., 2009). 
Along with the problem of frequent misdiagnosis, this strain has developed resistance to many 
commonly used anti-fungal drugs. The strain is likely almost always resistant to fluconazole but 





1.4 Candida albicans morphology 
C. albicans is a polymorphic fungus that grows in several different forms depending on a range 
of environmental cues. Under conditions that provide opportunity for infection, like low cell 
densities of competing organisms, (Hornby et al., 2001) Candida albicans will appear more in 
their hyphal form (known as psuedohyphae shown in figure 1.1). However, when living 
commensally, they exist in their more yeast like form (Lu, Su and Liu, 2014).  
 
Figure 1.1 Major morphologies of C. albicans. (Thompson, Carlisle and Kadosh, 2011). 
Visualised by differential image contrast (DIC) scale bar 10µm. Left, C. albicans in their yeast 
like form and schematic representation underneath. Right C. albicans in their pseudohyphal 
form and below a schematic representation of this.  
 
Although C. albicans predominantly exists in its yeast like form, when environmental aspects 
such as microbiota, temperature or host immunity change this gives C. albicans the 
opportunity to infect the host through its hyphal form. Initiation of the transformation can be 
triggered in a number of ways depending on the environmental cue, CO2 for example directly 
activates Cyr1 (Hall et al., 2010) whereas glucose as a signalling molecule activates expression 
of the Ras1 protein (Leberer et al., 2001) which then results in a signalling cascade of adenyl 
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cyclase Cyr1. This activates production of cAMP then activation of protein kinase A leading to 
the production of hyphae, critical for C. albicans virulence. Studies have shown that strains of 
C. albicans unable to produce hypha are avirulent (Lo et al., 1997).  
The presence of other microbes has also been shown to inhibit early stage morphogenesis of 
Candida albicans from their yeast like form to their hyphal form (Matsubara et al., 2016), (Cruz 
et al., 2013). For instance, within the gut biome Clostiridum difficile are a common organism 
and produce a substance called p-Cresol, which is toxic in high concentrations to most 
microbes but has been shown to directly inhibit the hyphal and biofilm formation of C. albicans 
(van Leeuwen et al., 2016). Studies like this have shown that there is more to the 
morphogenesis of C. albicans than environmental cues, and in complex environments like the 
gut biome, C. albicans may rely more on other microbes for signalling the start of infection. 
Biofilm formation is an important factor in the pathogenesis of C. albicans. A biofilm is a 
community of adherent cells with properties different to that of free floating cells. The 
formation of C. albicans biofilm is closely linked to its hyphal state and the formation of these 
biofilms is an important step in systemic infections. Cells adhere to a surface, regulated by Bcr-
1 and including Hwp1 and Als3 (Nobile et al., 2006) and begin to form hyphae which act as 
structural support for biofilm formation and with the regulation of Bcr-1 allows for the hyphae 
to adhere to one another (Nobile and Mitchell, 2005). These biofilms then produce an 
extracellular matrix, and release cells continuously. These released cells, although similar to C. 
albicans in their commensal state, exhibit increased adherence properties, the ability to form 








Figure 1.2 Structure of Candida albicans cell wall and membrane. The cell membrane is the inner 
most layer surrounding the contents of the cell, made up of a phospholipid bilayer. This is then 
surrounded by a layer of chitin, β 1,3 and β 1,6 - glucan comprising the inner wall. The outer wall is then 
a layer of mannoprotein (taken from Gow et al., 2011).  
 
The cell wall plays a crucial role in the virulence of C. albicans, containing many key proteins 
for the stages of infection.  Figure 1.2 shows a schematic diagram, along with an image of C. 
albicans cell wall and membrane. The cell wall has a layered structure with the inner wall 
comprised of chitin, a linear polysaccharide linked to β-1,3-glucans which provides the cell with 
structural integrity. β-1,6-glucan links the inner wall to the outer wall which is mainly 
comprised of mannan and β-1,6-glucan along with cell wall proteins. Beneath the cell wall is 
the cell membrane, structured the same as all mammalian cells, with a lipid bilayer. This lipid 
bilayer is interspersed with ergosterol (cholesterol in mammalian cells) an important sterol for 





1.4.2 Candida albicans pathogenicity 
Approximately 75% of women worldwide suffer from at least one case of vulvovaginal 
candidiasis in their life, with 40-50% of these suffering a reoccurrence (Sobel, 2007). 
Treatments for vulvovaginal candidiasis are readily available and infection causes a relatively 
small amount of damage to the host. However more serious infections occur in 
immunocompromised patients, as the host immune system, which monitors commensal 
growth and responds to pathogenic growth (mainly the formation of hyphae) is not fully 
functional thus allowing Candida albicans to readily form hyphae (Rast et al., 2016). 
There are three main stages of infection, adhesion, invasion and damage. The formation of 
hyphae is triggered by the adhesion of the cell to a mucosal membrane leading to the 
expression of two key hyphal proteins Hwp1 (Staab et al., 1999) and agglutinin-like sequence 3 
(Als3) (Zhao, 2004). Hyphal growth penetrates the epithelial tissue and secretes a cytolytic 
toxin called Candidalysin, a peptide encoded by the hypha-associated ECE1 gene, which causes 
significant damage. Candidalysin, when secreted in sufficient quantities, intercalates and 
permeabilises host epithelial membranes and induces cell lysis (Moyes et al., 2016). This leads 
to the formation of multiple necrotic nodules, which cause extensive organ damage and can 
eventually lead to organ failure. 
However, penetration of Candida albicans in the epithelial tissue is not the only concern. In 
2017 the rate of candidaemia was 3.6 per 100,000 population found in blood isolate. 42% of 
these were Candida albicans (Public Health England, 2018).  
 
1.5 Aspergillus fumigatus 
The thousands of species of fungi existing in many environmental niches make human contact 
with fungi a common occurrence.  Aspergillus fumigatus are a ubiquitous human fungal 
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pathogen, living in soil and decaying plant matter. The abundance of this organism is due to 
their ability to survive many environmental conditions. Like most human pathogens A. 
fumigatus has an optimal growth temperature of 37°C, however, unlike most other pathogens 
it has a high tolerance for temperature changes up to 60°C (Beffa, et al. 1998). The causes of 
this have been investigated and a link between thermotolerance and virulence was found. A 
fumigatus grows in hyphal form and spreads through its dispersion of spores.  In order for A. 
fumigatus spores to form hyphae they must germinate, in this process the number of 
ribosomes increases 10 fold to support hyphal growth (Brogden et al., 1984) 
 Aspergillus fumigatus is the most commonly recovered species from patients with 
aspergillosis followed by Aspergillus niger, flavus and terreus (Morgan et al. 2005). 
 
1.5.2 Aspergillus fumigatus morphology 
A. fumigatus are saprotrophic fungi thriving in soil with decaying plant and animal matter. A. 
fumigatus grows in multicellular branched structures in their hyphal form. However, when 
conditions are unfavourable A. fumigatus produces spores called conidia on specialised hyphal 
structures called conidiophores by a series of signalling cascades. These spores are then very 
efficiently (Taha et al., 2005) released into the air, where humans are estimated to inhale 100-
1000 conidia each day. Due to their small size(2-3µm) they can reach the alveoli of the lungs 
(Latgé, 1999) where they adhere to the surface. The cell wall of A. fumigatus conidia is similar 
to that of most fungal cell walls, with the presence of β 1,3 and β 1,6 - glucans and chitin, 
however they also contain a protective coating of melanin. The melanin is one of the reasons 
why the spores are so resilient. Melanin provides resistance to environmental stresses UV 
radiation and oxidising agents (Rosa et al., 2010).  The spores are able to reproduce asexually. 
Once the spores are established in an ideal growing environment the spores can then 
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germinate into full hyphae. The adherence of the spores to a suitable surface (like lung alveioli) 
is what triggers hyphal growth. 
1.5.3 Aspergillus fumigatus pathogenicity 
Rates of Aspergillus fumigatus infection in the UK are thought to be more substantial than 
previously reported. Groups of at risk patients include those living with AIDS, Patients who 
have undergone Haemopoietic stem cell transplants and those with chronic asthma (Baddley, 
2011). 
 
Invasive Infection Risk Group Number of Expected 
Cases 
Rates per 100,000 
population 
Invasive aspergillosis All risk groups* 
except critical care 
patients 
2901-2912 4.59 - 4.61 
 Critical care patients 387-1345 0.61 - 2.13 
Chronic pulmonary 
aspergillosis - all 




All risk groups*** 110,667-235,070 175 - 372 
Severe asthma with 
fungal sensitisation 
(SAFS) 
All risk groups**** 121,734-413,724 192- 654 
 Table 1.2. (Pegorie, Denning and Welfare, 2017) Total Estimates of the burden of various types 
of aspergilliosis on the at risk UK population. * Risk groups include: Allogeneic hematopoietic stem cell 
transplantation (HSCT) and autologous HSCT patients; solid organ transplants; people living with AIDS; Acute 
myeloid leukaemia (AML), Acute lymphoblastic leukaemia (ALL), Chronic myeloid leukaemia (CML), Chronic 
lymphocytic leukaemia (CLL), Non Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL) and Myeloma patients; 
Chronic granulomatous disease (CGD) patients; Chronic obstructive pulmonary disease (COPD): emergency hospital 
admissions,; critical care patients; patients with lung cancer. ** Risk groups include: pulmonary tuberculosis (PTB), 
non-tuberculous mycobacterial lung infection, COPD, sarcoidosis, and allergic aspergillosis complicating asthma. *** 
Risk Groups include: Asthma and Cystic Fibrosis. **** Risk Groups include: Severe Asthma, usually those with poor 
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control of the condition (treatment- resistant severe asthma, undiagnosed severe asthma and difficult to treat 
severe asthma). 
 
Table 1.2 shows the estimated rates of various A. fumigatus infections on at risk patient 
groups. Severe asthma with fungal sensitivity is predicted to be the most prevalent estimated 
to occur in 192-654 patients per 100,000.  
Little work has been done on determining the incubation time of A. fumigatus, however, Bénet 
et al., (2013) found that incubation times in patients with acute myeloid leukaemia can be 
around 15 days. This has a knock on effect in many aspects of fungal infection firstly in 
determining the location of infection source, meaning that other cases of infection cannot 
easily be prevented. Also that treating infections early are very difficult as by the time the 
patient becomes symptomatic the infection is already deep within the tissue. 
Once adhered A. fumigatus establishes hyphal growth and, as previously described in C. 
albicans, biofilms are also formed by A. fumigatus. These are often highly resistant to 
antifungal therapies, as pathogenic aspergilli can expel antifungal compounds using multidrug 
efflux pumps, this means that a high concentration of antifungal drug is necessary to 
successfully treat infection. (Kaur and Singh, 2014). 
The previously discussed melanin coating on the spores contribute greatly to the infectious 
capabilities A. fumigatus.  
1.6 Fungal infection diagnosis  
Currently fungal infections are diagnosed with a series of laboratory test including the use of 
microscopy, sample culture and histopathology. Sample culture is the starting point for most 
suspected cases of fungal infection. A sample is taken and grown on a variety of growth 
mediums to determine the type of infection. However, in the case of invasive Candidiasis, this 
process can take between 24 - 72 hours and can miss infection in around 50% of patients when 
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sampled from blood culture  (Ostrosky-Zeichner, 2012) and may only yield a positive result in 
late stages of infection (Ellepola and Morrison, 2005).  
Symptoms of Aspergillus fumigatus infection include a fever, chest and joint pain, shortness of 
breath and coughing up blood. Once symptoms present, diagnosis can be a difficult and 
lengthy process. Current diagnoses are based on the results following treatment with broad 
spectrum antibiotics. As the symptoms are non-specific they are often treated as a bacterial 
infection, after no response to antibacterial drugs thoracic imaging is used. Primarily a CT scan 
of the lungs is the first port of call (Lim et al., 2012). 
 
1.7 Fungal infection treatments 
There are four main classes of antifungals. Firstly azoles, including the commonly prescribed 
fluconazole. These act by inhibiting synthesis of the cell membrane component ergosterol, by 
inhibiting the cytochrome p450 enzyme 14-α lanosterol demethylase which catalyses the 
conversion of lanosterol to ergosterol (Kathiravan et al., 2012).   
The next class are polyenes, most commonly prescribed being Amphotericin B which again 
targets ergosterol in the cell membrane. Amphotericin B binds to ergosterol in the membrane 
causing the formation of pores which leads to depolarisation of the membrane, leakage of 
intercellular components and eventually cell death (Brajtburg et al., 1990). 
Echinocandins are lipoproteins that act as non-competitive inhibitors of β 1, 3 – glucan 
synthase required for the synthesis of cell wall component β 1, 3 -glucans (Perlin, 2011). 
Defects in the synthesis of cell wall components affect the integrity of the cell and result 
osmotic sensitivity, reduced sterol contents and thickened cell wall.  
Finally, pyrimidine analogs like 5- flucytosine, impair fungal cells ability to synthesise proteins 
and DNA during nuclear division. (Waldorf and Polak, 1983. Diasio et al. 1978). This comes as a 
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result from the rapid conversion of 5-FC to 5-fluorouracil in susceptible fungal cells by the 
enzyme cytosine deaminase.  
  
1.8 Fungal infection treatment complications including the similarity of fungal cells to 
human cells 
Antifungal treatments have been proven to be relatively effective over the years, with 
variations in drug types and their targets meaning there are a wide range of options available 
for treatments. However, as with bacterial infections, treatment options are becoming much 
narrower with the emergence of antifungal resistant strains of fungi. 
The class of antifungals echinocandins for example have seen reported cases of resistance 
after just one week of treatment (Lewis et al. 2013).  Mechanisms of resistance vary by 
treatment and species of target. The most common factors contributing to antifungal 
resistance are the selective pressures these treatments place on the population of fungi. The 
most common being mutations that result in conformational changes to the target site. In C. 
albicans multiple strains resistant to azoles have been found to have a single mutation Tyr132 to 
Phe substitution in Cyp51 (Cools, 2008).  
Another factor of resistance is in the formation of biofilms during infection. There is an 
extracellular matrix present around the cells that comprise the biofilm, this extracellular matrix 
in A. fumigatus contains galactomannan, galactosaminogalactan, α-1,3 glucans, 
monosaccharides, polyols, melanin, and proteins (Beauvais and Latgé, 2015). In addition to this 
in a biofilm A. fumigatus releases extracellular DNA, which aids antifungal resistance 
(Rajendran et al., 2013 and Jöchl et al., 2009)  
A major issue of anti-fungal treatments is the target cells similarity to human cells. The main 
sterol component of fungal cell membranes is ergosterol, this is very similar to the cell 
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membrane sterol cholesterol in mammalian cells. Cholesterol is also synthesised in a pathway 
utilising members of the cytochrome p450 enzyme class. However, amphotericin B exhibits 
high nephrotoxicity (Torrado et al., 2008). These adverse effects are not limited to one class of 
antifungals, Itraconazole for example was found to have a 23% chance of treatment being 
discontinued due to adverse effects (Wang et al. 2010). 
Echinocandins have low bioavailability due to their large molecular weight; this means that 
they must be administered intravenously.  However, they have relatively low toxicity toward 
mammalian cells as they target the cell wall of fungi and therefore don’t affect mammalian 
cells (Shapiro, Robbins and Cowen, 2011). 
1.9 Aptamers 
The term aptamer refers to a section of DNA/RNA or protein that has specific binding to a 
target. These highly specific molecules have a high affinity for their targets as a result of the 
way in which they are produced. SELEX (Systemic Evolution of Ligands by Exponential 
enrichment), the means for in vitro selection of aptamers, was developed in the 1990s and 
demonstrates the ability of aptamers to bind to a wide variety of targets, from small molecules 
to large protein complexes (Tuerk and Gold, 1990). 
 
1.9.2 Systematic Evolution of Ligands by Exponential Enrichment (SELEX) 
SELEX is carried out by taking a target cell or molecule and incubating with a pool of random 
aptamers. Non-binding aptamers are removed and binding aptamers, eluted and amplified by 
Polymerase chain reaction (PCR). These aptamers are then incubated with targets again. This 
process is repeated and with each round of SELEX the pool of aptamers reduces to aptamers 
that bind specifically to the target. Some studies performed include the introduction of a 
counter selection step where the aptamer is incubated with a protein or cell type similar to the 
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target. Aptamers that do not bind during the counter selection step are taken forward to 
incubation with the target, whilst aptamers that did bind during counter selection are 




Figure 1.3, SELEX. A schematic diagram of the SELEX process. A random library of aptamers is incubated with 
the target molecule to determine which will bind. Non-binding sequences are separated off, and binding aptamers 
are eluted and amplified. The binding aptamers can then be identified and sequenced. The process is then repeated 
with the addition of new random aptamers to increase numbers of binding aptamers. (Blind and Blank, 2015). 
 
Figure 2 shows the SELEX process and how aptamers are identified for specific targets through 
the amplification of binding sequences and elimination of non-binding sequences. Once 





1.9.3 Structure and Function 
Aptamers are single-stranded DNA or RNA of 20-100 bases in length. Their unique properties 
are based on their ability to fold into unique secondary and tertiary structures because of the 
wide variations in size and sequence of each strand.  
1.9.4 Aptamers versus Antibodies 
Antibodies also have the ability to bind to specific targets, however, aptamers have a number 
of key advantages. Firstly in order to carry out the SELEX process the target of the aptamer 
does not have to be predetermined. This means that an aptamer will be selected on the 
affinity of its binding not the suitability of the target. Whereas antibodies are produced based 
on their specific antigen. Aptamers also offer many other advantages over antibodies, due to 
their oligonucleotide properties. (Sun et al. 2014). Aptamers have a lower molecular weight of 
around 8-24 kDa compared to antibodies at around 150 kDa, because of this, aptamers can 
penetrate tissue faster and more efficiently enabling smaller doses of drugs to be used as more 
would get to the target tissue and not be distributed and lost to the other parts of the body. 
Also directly compared to antibodies, aptamers have been shown to penetrate tissue faster 
and more efficiently in cases of cancer where tumours are denser than the surrounding tissue 
(Xiang et al., 2015) which, with antibodies, would mean reaching the centre of the tumour 
would be difficult. 
They have also been shown to not illicit an immune response in vivo (Eyetech study group, 
2002), which brings fewer complications for patients. Another issue with antibodies is their 
stability. A common cause of physical instability is aggregation of antibodies (Shire, Shahrokh 
and Liu, 2004). The higher the concentration of antibodies the more likely they are to form 
aggregates. Aggregates of immunoglobulin have also been shown to cause renal failure 
(Demeule, Gurny and Arvinte, 2006). Aptamers are more stable, due to the conditions which 
affect the folding of aptamers like pH, Magnesium (Mg) concentration and temperature. In a 
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clinical setting, within patients or patient samples these values do not vary enough to affect 
the binding and folding of DNA.  If a selection is carried out under the right conditions the 
aptamer will continually fold in the same way meaning that problems of aggregation don’t 
occur. Aptamers can be made more stable with the addition of post SELEX modifications 
(Boomer et al., 2005, De Smidt et al., 1991). 
1.9.5 Previously Identified aptamers 
In regards to microorganisms, previous studies mainly focus on the application of aptamers in 
bacterial treatments/detection. Chang et al. (2013) found two aptamers that selectively bind 
to Staphylococcus aureus with high affinity. Hamula et al. (2008) performed selections against 
live whole bacterial cells. Tang et al. (2016) found aptamers that specifically bound to β 1,3 - 
glucan in the membrane of C. albicans. 
1.9.6 Aptamers as therapeutic agents 
Aptamers have been used to fluorescently tag and bind to tumour initiating cells, a common 
precursor in brain cancer, thus indicating their diagnostic potential as a means of detecting 
tumour initiating cells (Kim et al., 2013). Many groups have demonstrated that aptamers with 
specificity to cell surface receptors can greatly aid the internalisation of drugs such as 












2.1 Fungal cell growth and maintenance 
Candida albicans (C.albicans), strain SC5314, and Saccharomyces cerevisiae (S. cerevisiae), 
strain BY4741a a derivative of S288C (MATa his31 leu20 met150 ura30) (Baker Brachmann et 
al., 1998) were grown in YPD broth (1% yeast extract, 1% peptone and 2% dextrose) at 30oC 
with shaking at 180 rpm and stored on YPD agar (YPD broth, 1% agar). Aspergillus fumigatus 
(A. fumigatus), strain ATCC 4660, was grown on Sabouraud (SAB) agar (4% glucose, 1% 
peptone, 2% agar, pH5.6) at 30oC.  
2.1.2 HeLa cells 
The HeLa cell line (obtained from ATCC, Manassas, USA) were maintained in Eagle’s Minimum 
Essential Media (EMEM, Earle's Balanced Salt Solution, non-essential amino acids, 2 mM L-
glutamine, 1 mM sodium pyruvate, and 1500 mg/L sodium bicarbonate.) supplemented with 
10% Foetal Bovine Serum (FBS), 1% non-essential amino acids (NEAA), 2mM L-glutamine, 1mM 
sodium pyruvate and 10U/ml Pen-Strep. Cells were grown in a 75ml flask, in a 37ºC, 5% CO2 
static incubator to around 80% confluency before being passaged. Cells were washed twice 
with phosphate buffered saline (PBS) (10mM phosphate, 137mM sodium chloride, 27mM 
potassium chloride, pH 7.41) then adding 3ml of 1x trypsin and incubating for 5 minutes at 
37ºC, in order to detach cells from the surface of the flask. Once detached the trypsin was 
neutralised by adding an equal quantity of EMEM (all solutions pre warmed to 37ºC), before 
being centrifuged at 570g for 5 minutes and pelleted cells re-suspended in fresh EMEM. Cells 
were only passaged to around passage 15, at this point cell lines were disposed of and a new 
line taken from cryogenic storage, defrosted and grown.  




Figure 2.1 A summary of the SELEX protocol (Schütze et al., 2011). The diagram shows the 
amplification of the initial library to generate the starting pool of aptamers, these are then incubated 
with the target. Non-binding aptamers are washed from the target, and the remaining bound aptamers 
are eluted and then amplified. These either form the pool for the next round of selection or are used for 
binding and diversity assays or sequencing.  
2.2.1 Amplification and purification of DNA Aptamer Library  
Figure 2.1 shows an overview of the SELEX process. Starting with a random library of aptamers, 
which were used to provide the stock aptamer library. This library consists of a random 1015 
DNA aptamers, synthesised by Integrated DNA Technologies (IDT, UK) through machine mixed 
randomisation. Each sequence (green) was flanked by aptForward (red) and aptReverse (blue) 
primer specific to the aptamer library.  
 5’- ATCCTAATACGACTCACTATGGGGAGAGGATTCTGGGCACAAGCGAATTTATATAAAGC 
CCGGCTCAACTGGCAAAGCAATCGGTCGAGTTTACCGCAGAATT – 3’ 
For amplification of each aptamer by PCR both primers are needed. 
 
An initial amplification of the aptamer library was undertaken by Polymerase Chain Reaction 




Table 2.1 Reagents used in the PCR reaction for amplification of aptamers. 
Reagent Final Concentration 
10x Taq Buffer 1x 
Deoxynucleotide Solution (10mM) 200µM 
AptForward (100µM) 2µM 
AptReverse (100µM) 2µM 
Sample/ Aptamer Library (100µg/µl) 10µg/µl 
MgCl2 (25mM) 4mM 
DMSO 5% 
DNA Taq Polymerase (4U/µl) 0.02 U/µl 
 
Table 2.2 PCR conditions for amplification of aptamer library. 
Action Time (sec) Temperature (ºC) 
Initial Denaturation 300 95 
        Phase One (10 Cycles)  
Denaturation 30 95 
Annealing 30 60 (decreased 1ºC/cycle) 
Extension 30 72 
        Phase Two (10 Cycles)  
Denaturation 30 95 
Annealing 30 64 
Extension 30 72 
   
Final Extension 420 72 
 
Confirmation of aptamer amplification was by visualisation of the PCR product on a 2% 
agarose gel, containing 0.005% Gel Red (see section 2.2.5) PCR products were pooled and 
concentrated by ethanol precipitation (see section 2.2.6). 
2.2.2 Aptamer preparation 
Concentrated PCR products (see section 1.2.4) were added to binding buffer (25mM glucose, 
0.1% bovine serum albumin, 0.25mM MgCl2 and 1x PBS), and heated to 95ºC for 5 minutes. 
The DNA aptamers were then snap cooled on ice for at least 10 minutes and kept on ice or at 
4ºC until required. 
2.2.3 Negative Selections 
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The DNA aptamer library and aptamers from each subsequent round were first incubated with 
HeLa cells, to ensure only aptamers that did not bind to HeLa cells were selected. HeLa cells 
were prepared for either room temperature or 4°C by first, washing in wash buffer (1x PBS, 
25mM glucose, 0.25mM MgCl2), before being  re-suspended in 175µl binding buffer at the 
required concentration, approx. 60,000 cells/ml (total 10,000 cells). HeLa cells were then 
incubated for 1 hour at 4°C or room temperature on a rotor at 20rpm. Samples were then 
centrifuged at 570g the supernatant was removed and kept for positive selection, while the 
pellet containing the cells and any bound aptamers was discarded.  
2.2.4 Positive Selections and controls 
 C. albicans and S. cerevisiae cultures were diluted to a concentration of 3x106CFU/ml during 
exponential growth phase. Cells were then centrifuged at 2660g for 2 minutes, washed with 
washing buffer to remove any remaining YPD media, and then re-suspended in 175µl of 
binding buffer. A. fumigatus spores were prepared by using an inoculating loop to gently 
scrape the spores from the surface of the plate and re-suspend in binding buffer. Aptamers 
were incubated at 4°C to restrict active uptake processes in the cell, in order to select an 
aptamer which bound the cell wall. Room temperature selections were performed to allow 
these processes to happen, in order to find an aptamer that is internalised by the cell. 
The supernatant from the negative selection was incubated with either C. albicans or A. 
fumigatus for 1 hour at 4°C or at room temperature on a rotor spinning at 20rpm. After 
incubation cells were washed 5 times with washing buffer, to remove any unbound aptamers, 
before being resuspended in 200µl of dH2O and heated at 95ºC for 10 minutes to elute bound 
aptamers. The samples were centrifuged at 15,000g for 1 minute and the supernatant 
retained. A test PCR was initially conducted to ensure elution of aptamers, before further 
amplification by PCR, purification and concentration, by ethanol precipitation. The resulting 
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PCR product was continued into subsequent rounds of selection (see section 1.2). A total of 10 
rounds of SELEX were completed for each condition (represented in figure 2.1).  
To ensure no amplification of non-specific sequences, the experiment was also undertaken 
with aptamer alone and fungal cells alone. When visualising resulting PCR products from each 
elution (see section 2.2.5), if a band was seen in either control this would indicate non-specific 
amplification and the round of SELEX was repeated from the previous round’s elution. 
2.2.5 Separation, Visualisation and Purification of PCR products 
PCR products were run on a 2% agarose gel prepared with 1x TAE buffer (1.85M Tris, 45mM 
EDTA and 1M glacial acetic acid), containing 0.002% Gel Red. Samples were prepared by 
mixing with 1x Orange G (0.2% Orange G, 4% glycerol) and then  run at 100volts on an agarose 
gel with a DNA ladder sample containing DNA fragments of a known size mixed (Thermo 
Scientific, UK). Gels were then imaged using UV light (Bio-Rad ChemiDoc XRS+ with Image Lab 
software). Successful amplification was determined by the presence of a band at approx. 
105bp, with no bands present in the relevant controls. If non-specific bands were also 
observed within the reaction, the required band was purified  by gel extraction using a Gel 
Extraction kit (Nucleospin Gel and PCR Clean-up, Machery-Nagel UK) as per the manufacturer’s 
instructions. The final product was then diluted approx. 1/50 and used as a template for PCR 
amplification of the purified aptamers.  The resulting PCR product was then concentrated by 
ethanol precipitation and continued into the next round of selection. 
2.2.6 Ethanol precipitation of PCR products 
Following PCR amplification, the purified aptamers were pooled and concentrated by ethanol 
precipitation. 1/10th the volume of 3M sodium acetate (NaAc) was added along with 2x volume 
of ice cold ethanol (100%) and incubated at -80°C for 1 hour. Samples were then centrifuged at 
17,000g, 4°C for 10 minutes, the supernatant removed, and the DNA pellet washed with 70% 
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ethanol and centrifuged at 14,000rpm for 5 minutes. 70% ethanol was then removed, and the 
pellet re-suspended in dH2O. Concentrations of each sample were determined using the 
Nanodrop 2000. 
2.3 Cloning and Sequencing of Aptamers 
2.3.1 Transformation and cloning of Aptamers 
After 10 rounds of SELEX, purified DNA aptamers were ligated into a TOPO 2.1 vector 
(Invitrogen) as per manufacturer’s instructions. These ligated plasmids were transformed into 
chemically competent DH5α Escherichia coli (E. coli) () (genotype: F- φ80 (lacZ)ΔM15 ΔlacX74 
hsdR (rk-, mk+) ΔrecA1398 endA1 tonA) prepared by calcium chloride method. Cells were 
incubated on ice for 1 hour, heat shocked at 42ºC for 90 seconds, snap cooled on ice for 2 
minutes and then recovered in LB media (63.5mM tryptone, 0.17 1M sodium chloride (NaCl), 
0.5% yeast extract) at 37ºC for 1 hour. Recovered E. coli were plated onto LB agar (LB broth, 1% 
agar) containing 25µg/µl ampicillin and incubated overnight at 37ºC.  
Colonies from the plates were re-suspended in dH2O, and initially screened for correctly 
ligated inserts by colony PCR using M13 forward and reverse primers. Results were visualised 
on a 1% agarose gel (as per section 1.2.3).  
Table 2.3 - Reagents used for colony PCR 
Reagent Final Concentration 
10x Taq Buffer 1x 
MgCl2 (25mM) 0.5mM 
dNTPs (10mM) 200µM 
M13 forward or Aptfor (100µM) 2µM 
M13 Reverse or Aptrev (100µM) 2µM 
E. coli Sample  
DNA Taq Polymerase (4U/µl) 0.02U/µl 
 
 
Table 2.4 – Colony PCR programme. 
Action Time (sec) Temperature (ºC) 
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Initial Denaturation 300 95 
Denaturation 30 95 
Annealing 30 45 
Extension 30 72 
Final Extension 420 72 
 
 Positive samples were checked with aptforward and aptreverse primers, then inoculated into 
LB media with 25µg/µl ampicillin and grown overnight at 37ºC with shaking at 180rpm. E. coli 
cells were then harvested by centrifugation at 10,000 x g and the plasmid purified as per 
manufacturer’s instructions using a GeneJet Plasmid Miniprep Kit (Thermo Fisher Scientific). 30 
cycles. 
2.3.2 Sequencing of Aptamers 
Purified plasmids were sent to Source Biosciences (Nottingham, UK) for Sanger sequencing, 
using M13 forward and reverse primers. Sequences were analysed using Clustal Omega 
(available at: https://www.ebi.ac.uk/Tools/msa/clustalo/) to determine sequence similarity. 
Structures of each DNA aptamer were predicted using Mfold software (available at: 
http://unafold.rna.albany.edu/?q=mfold/DNA-Folding-Form) under the conditions each 
aptamer binds to its target molecule in (137mM [Na+], 0.25 mM [Mg++] and at either 4ºC or 
25ºC). 
2.4 Testing of Purified aptamers 
2.4.1 Aptamer Binding using PCR 
Isolated aptamers were initially screened for their binding affinity and specificity via PCR. 
Aptamers were prepared, at a final concentration of 50nM - 200nM, (see section 2.2.2) and 
incubated for 30 minutes with C. albicans, S. cerevisiae and A. fumigatus separately at either 
4ºC or room temperature Cells were washed 5 times with washing buffer and resuspended in 
200µl of dH2O.  Bound aptamers were eluted by heating to 95°C for 10 minutes and underwent 
PCR (as described in section 1.2.2). PCR products were then visualised on 2% agarose gel, 
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alongside 95ng of aptamer library, concentration of 23.75ng/µl. Gels were then analysed by, 
Bio Rad Chemidoc XRS+, Image Lab+ software and the amount of DNA aptamer from each 
sample calculated by comparison to the intensity of the band from the aptamer library sample. 
The exposure time for each image was 0.5 seconds.   
2.4.2 Fluorescence microscopy 
Isolated aptamers were ordered tagged at the 5’ end with a fluorescent tag, either Alexa 488 
or Cy5, from IDT (UK). These aptamers were prepared as previously described (section 1.2.2) to 
a concentration of 200nm and incubated for 30 minutes, at either 4oC or RT with the relevant 
fungal species (as per section 2.1.1). Cells were then washed five times with washing buffer 
before being fixed in 3.7% formaldehyde (37% fomaldehyde, 1x PBS) for 15-20 minutes at 
room temperature, washed with 1x PBS and re-suspended in vectashield with DAPI for 
mounting onto slides. Cells were then imaged using Zeiss Fluorescent Microscope. For each 
slide a representative sample was imaged with a Brightfield, DAPI, Alexa 488 and Cy5 filter 










3.1 Selection of aptamers against Candida albicans and Aspergillus fumigatus with different 
incubation conditions. 
The SELEX process was previously adapted from the protocol established by Sefah et al. (2010), 
and optimised to select aptamers specific for the fungi, C. albicans and A. fumigatus. The SELEX 
process was carried out at either 4°C or room temperature. This was to enable selection of 
aptamers specific to either the outside of the cell (wall and membrane) or those internalised 
into the cell, due to the changes is membrane fluidity caused by the differences in 
temperature, and the activity of uptake processes in to the cell. After initial amplification, by 
PCR, and concentration, via ethanol precipitation, the aptamer library was first incubated at 
4°C or room temperature for 1 hour with HeLa cells, as a negative selection.  Due to the 
similarities between these eukaryotic species, mammalian cells were used as a negative 
selection in order to select aptamers more specific to fungal species. Any unbound aptamers 
were then incubated with the appropriate fungal species at either 4oC or RT, along with 
controls containing no aptamer to ensure that any amplification is not due to non-specific 
DNA. At the end of each round of selection, a test PCR was conducted on the elution and the 
amplified aptamers, of 105bp in size, were purified by gel extraction. This ensured only 
aptamers of the correct size were amplified and carried through to subsequent rounds of 
SELEX. Ten rounds of selection were undertaken for each condition and fungal species.  Figure 
1, shows the PCR amplification from the elution following each round of selection in C. albicans 





(A) Candida albicans 4ºC 
105bp 
Control 
                        R1           R2          R3          R4        R5         R6          R7          R8          R9          R10 
(B) Candida albicans Room Temperature 
105bp 
Control 
                        R1         R2          R3           R4         R5          R6         R7         R8         R9         R10 
Figure 3.1. Amplification of aptamers from SELEX rounds 1 to 10 of selection in Candida 
albicans at 4ºC and room temperature. Aptamer library (round 1) or product from the previous 
round of selection (each subsequent round) was incubated for 1hr with C. albicans at either 4°C (A) or 
room temperature (B) and a control with no aptamer. Cells were washed and any bound aptamer 
eluted. A PCR from a sample of each elution was undertaken and run on a 2% agarose gel, imaged at an 
exposure of 500ms using BioRad ChemiDoc XRS+ Image Lab software. 
 
(A) Aspergillus fumigatus 4°C 
105bp 
Control  
                        R1         R2         R3        R4        R5       R6         R7        R8         R9       R10  
(B) Aspergillus fumigatus Room Temperature 
105bp 
Control 
                        R1          R2          R3          R4          R5          R6           R7         R8          R9         R10 
Figure 3.2. Amplification of aptamers from SELEX rounds 1 to 10 of selection in Aspergillus 
fumigatus at room temperature and 4°C. Aptamer library (round 1) or product from the previous 
round of selection (each subsequent round) was incubated with A. fumigatus spores at either 4°C (A) or 
room temperature (B) and a control with no aptamer. Cells were washed and any bound aptamer 
eluted. A PCR from a sample of each elution was undertaken and run on a 2% agarose gel, imaged at an 








Figures 3.1 and 3.2 show the PCR product from each round of selection at 4°C (A) and room 
temperature (B) along with the no aptamer control from each round.  The presence of bands 
on the agarose gel was used to preliminarily determine whether aptamers had been isolated 
and whether the amount eluted from cells was sufficient to continue to the next round. The 
controls were used to confirm the lack of non-specific DNA amplification. In all cases no band 
was detected in the control indicating that the amplified band was due to the presence of 
aptamers. For round 1 (figure 3.1A and B and figure 3.2A and B), a clear band at 105bp 
indicates amplification of aptamers following PCR.  The overall intensity of this band decreases 
for each subsequent round of selection with slight increases in rounds 5, 7 and 8 for figure 1A 
and rounds 3, 4 and 8 for figure 3.1B. For figure 3.2A the intensity decreases up until round 9, 
where there was a slight increase, which then decreased again at round 10. Figure 2B shows 
more of a steady decrease throughout the rounds. Despite the varying intensities, it is still 
evident that following round 10 of SELEX all conditions have produced elutions that contain 
aptamers isolated against the target cells through each round of selection.  
3.2 Isolation and Sequencing of Aptamers 
To isolate these individual aptamers, the PCR product from round 10 was ligated into the 
TOPO cloning vector (Invitrogen), which relies on the A overhang added by Taq polymerase. 
After ligation, the resulting plasmids were transformed into chemically competent DH5α E. 
coli. Colonies were grown and selected, before the plasmids were purified. The resulting 
plasmids were then tested for successful cloning of the aptamer insert by PCR using 
aptForward and aptReverse primers. The resulting PCR products were run on a 2% agarose gel 









                   CaRTA       B        AfRTA      B          C            D     Af4A        B        Ca4A         B         C 
Figure 3.3. Successful cloning of aptamer sequences into TOPO vector was confirmed by PCR. 
A sample was taken of each mini prep and tested by PCR using aptForward and aptReverse primers, all 
11 samples were tested and all 11 were positive for an aptamer insert. CaRTA and B were positive 
colonies from C. albicans at room temperature, AfRTA, B, C and D were positive colonies from A. 
fumigatus at room temperature. Af4A and B were positive colonies from A. fumigatus at 4°C and Ca4A, 
B and C were positive colonies from C. albicans at 4°C. 
 
11 colonies in total were obtained and tested, resulting in 3 positive colonies for C. albicans at 
4°C, 2 positive colonies for C. albicans at room temperature, 2 positive colonies for A. 
fumigatus at 4°C and 4 positive colonies for A. fumigatus at room temperature. Each positive 
plasmid was then sent for sequencing using the M13 reverse primer.  
Each sequence was then analysed, without the primer sequences, through Clustal Omega 
analysis software. The analysis from this software shows the similarities between the aptamers 
allowing for sequence comparisons. Sequences, with the primer sequences, were also 
analysed by Mfold analysis software to predict secondary folding structure of each aptamer, 









AF4A       -------GCGGGAGAGAATTCAACAACAATGC-AGTCCAGGGACAGAGACAGACAGCAACACGA----------AGCTCCACG--------- 
AFRTD      ----CCGACGACAGAGTAAGGGGG-GAC--------AATCAGACAG---GAATGACAGGGACAAC------------------------G-- 
CARTA      ----CGAGAGGGAGAGAGAGGGAGAGAGAGGCAGAGACAGAGACAGAGAGAAAGAGAGAGACAATTCTGCGGTAAACTCGAAGGACAGCC-- 
CARTB      ----------------------------AGGCAGGAGGGAGATGAGGAGTGGTGAGCGGGATAAGCGTGGGGAG---AGCGGTG-------- 
CA4A       --------------------GGGCACACGAACAGAAGCGGCAAGACAAGGGGGGAATAACACAAGACGAAGGACCAGGCACGTG-------- 
AF4B       -------------------AGGCAAGACAAACAAGAGCGAACAGGGAACGGAAA-------------AGCGAACAATGCAC----------- 
AFRTB      --------GGGGAGAGGATTCTGGGCACAAGCGAATTTATATAAAGCCCGGCTC--------------------AACTGGCAAAGCAATCGG 
AFRTC      --------GGGGAGAGGATTCTGGGCACAAGCGAATTTATATAAAGCCCGGCTC--------------------AACTGGCAAAGCAATCGG 
CA4C       TGCCTGGTGTTGTGATTGTCCCCCCCTCGTTG------TTGTTCCCGTGTGCTG--------------------TGC---CGTT-------- 
AFRTA      --CCTAATACGACTCACTATCCTAA----TACGACTCACTATCCACACGCACAT--------------------CAC--CCGTTG------- 


















Figure 3.4.  Analysis of aptamer sequences via Clustal Omega (A) Phylogenetic tree of isolated aptamer. Isolated sequences from the SELEX process were put 
through Clustal Omega software (primer sequences removed) and sequences compared for similarity shown as a phylogenetic tree. (B) AlignMent of isolated aptamer 
sequences. Clustal Omega ouput of sequences aligned. (C) Percentage similarity of all isolated sequences. Clustal Omega output of similarity of sequences expressed 
as percentage values between each sequence. 
Aptamer % Similarity 
 Af4A AfRTD CaRTA CaRTB Ca4A Af4B AfRTB AfRTC Ca4C AfRTA Ca4B 
Af4A 100 37.78 60.00 34.15 32.69 29.27 44.44 44.44 23.40 34.69 30.19 
AfRTD 37.78 100 64 42.31 42.42 43.48 45.71 45.71 25 17.14 26.32 
CaRTA 60 64 100 39.62 42.19 44.90 45.16 45.16 15.69 25.45 22.41 
CaRTB 34.15 42.31 39.62 100 47.17 40.54 24.24 24.24 41.67 20 19.35 
Ca4A 32.69 42.42 42.19 47.17 100 56.25 29.55 29.55 31.43 31.58 23.81 
Af4B 29.27 43.48 44.90 40.54 56.25 100 35.71 35.71 12.12 27.78 20 
AfRTB 44.44 45.71 45.16 24.24 29.55 35.71 100 100 31.91 33.33 38.89 
AfRTC 44.44 45.71 45.16 24.24 29.55 35.71 100 100 31.91 33.33 38.89 
Ca4C 23.40 25 15.69 41.67 31.43 12.12 31.91 31.91 100 36.73 53.85 
AfRTA 34.69 17.14 25.45 20 31.58 27.78 33.33 33.33 36.73 100 49.09 
Ca4B 30.19 26.32 22.41 19.35 23.81 20 38.89 38.89 53.85 49.09 100 
34 
 
The phylogenetic tree (figure 3.4A) groups aptamers together based on their similarities in 
sequences. Sequences were grouped into three main families, which may suggest three distinct 
epitopes. The first branch contains 6 aptamers, the second branch contains 2 aptamers of the same 
sequence, AfRTB and AfRTC, and the third branch which contains 3 aptamers. Within the first 
branch, AFRTD and CARTA are more closely related, as are CA4A and AF4B. In the third branch, CA4C 
and CA4B are more closely related to each other than AFRTA.  Based on the sequence homology, the 
majority of aptamers showed less than 60% similarity (Figure 3.4B and 3.4C) Ca4C and Af4B show 
the largest difference with only 12.12% similarity. Within each SELEX condition sequences show 
varying amounts of similarity. C. albicans at 4°C isolated sequences Ca4B and Ca4C show 53.85% 
similarity but only 23.81% (Ca4B) and 31.43% (Ca4C) to Ca4A. C. albicans at room temperature 
isolated sequences CaRTA and CaRTB show 39.62% similarity, with similar sequence alignments both 
showing long sequences rich in A and G. However CaRTA is 33 bases longer. Between the 2 
conditions again shows varying similarity, with the most similar being Ca4A and CaRTB at 47.17% 
similarity and the least being Ca4C and CaRTA with a 15.69% similarity. Aptamers selected at room 
temperature against A. fumigatus again show varying levels of similarity with the largest similarity 
(excluding the 100% similarity between AfRTB and AfRTC) between AfRTB/C and AfRTD at 45.71%, 
followed by AfRTA and AfRTB/C at 33.33% and finally the lowest similarity between AfRTD and 
AfRTA at 17.14%. For selection in A. fumigatus at 4°C Af4A and Af4B shared a 29.27% similarity. 
Figure 3.4B shows the sequence alignments generated by clustal omega, which demonstrates there 
were very few conserved regions between all aptamers. However, based on the phylogenetic 
mapping a number of aptamers were found to be closely associated. Therefore, these sequences 









Figure 3.5.  Alignment of isolated aptamer sequences using Clustal Omega. (Alignment of two 
aptamers) (A) AFRTD and CARTA (B) CA4A and AF4B (C) CA4C and CA4B. Conserved regions are indicated in 
yellow and with a *. 
 
 
Based on the phylogenetic tree, the closely related sequences AFRTD and CARTA showed 32 
consensus bases, with one group of 6, one group of 5 and two groups of 4 conserved bases (Figure 
3.5A). CA4A and AF4B, were also shown to be closely related showing 26 consensus bases, with one 
group of 5 and one group of 4 conserved bases (Figure 3.5B). Finally, CA4C and CA4B showed 25 
consensus bases, with one group of 5 conserved bases (Figure 3.5C). 
 
3.3 Predicted Aptamer Folding structures.
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(D). Sequences from A. fumigatus at room temperature predicted folding structure. 
     Figure 
3.6. Structure Analysis of Aptamer Sequences via Mfold (A) Sequences from C. albicans at 4°C predicted folding structure. (B) Sequences from C. albicans 
at room temperature predicted folding structure. (C) Sequences from A. fumigatus at 4°C predicted folding structure. (D) Sequences from A. fumigatus 
at room temperature predicted folding structure. All sequences were analysed using Mfold software and folding structure predicted based on SELEX 
conditions (Na+ 137mM and Mg++ 0.25mM) and 4°C or room temperature based on which SELEX condition. Structures shown are those with the lowest 
predicted Gibbs free energy. Aptforward primer sequences are highlighted in red and Aptreverse sequences highlights in blue.
40 
 
3.4 Characterisation of Isolated Aptamer 
Aptamers are strands of DNA that are able to fold into a 2D stable structure through complementary 
base pairing. By predicting the secondary structure of the aptamer, the bases available to bind to the 
target can be identified. Sequences were analysed using Mfold software and the folding structure 
based on conditions for each selection (Na+ 137mM and Mg++ 0.25nM and either 4°C or room 
temperature). These were set by ion concentrations contained within the binding buffer used for 
incubating aptamers with target cells. 
For each structure, the Gibbs free energy (ΔG) is determined, which refers to the amount of energy 
needed to disrupt the structure and break the bonds formed in each strand of DNA. The structure 
with the lowest Gibbs free energy was selected as this is most likely structure for the strand to form 
naturally.  
The structures of each aptamer show large similarities within each condition. Both aptamers Ca4B 
and Ca4C (figure 3.6A) have large loop regions and Ca4A (figure 3.6A) a smaller loop region and have 
the highest ΔG compared to aptamer structures from the other SELEX conditions. Aptamers from C. 
albicans selections at room temperature (figure 3.6B) again show similarities in structure, both 
consisting of a larger loop region with 3 stem and loop structures. The predicted secondary 
structures of aptamers from A. fumigatus at 4°C (figure 3.6C) have the lowest ΔG value compared to 
other conditions. Af4A and Af4B have larger portions of stem structures than other structures. This is 
stark contrast to aptamers selected against A. fumigatus at room temperature (figure 3.6D), which 
comprise of much larger loop regions with few stem portions. There appear to be no major 
consistencies between the selection temperature or what species the aptamer was selected against, 
with the exception of Ca4C which shares more similarities in the large central loop region, branching 




To confirm whether the aptamers where able to bind to the target cells they were isolated against, 
the purified aptamers were tested to confirm binding and specificity using PCR. All aptamers were 
amplified by PCR and tested at a concentration of 200nM, as described by Apetkhar et al. (2015), 
both at room temperature and 4°C Aptamers were incubated with each cell type at the required 
temperature for 30 mins. The reduced incubation time ensured that only aptamers with high affinity 
to the target were identified.  Following incubation, aptamers were eluted from the cells and 
amplified by PCR before being analysed by gel electrophoresis. Concentration of the amplified 
aptamer was determined by comparison to a sample of known concentration on the same gel and 
analysed using ChemiDoc XRS+ software. It was assumed that the concentration of aptamer, 
following PCR, would be related to the amount of aptamer that bound to the cells. For each species 
incubated with the various aptamers a previously identified aptamer (C9 for C. albicans and Af20 for 
Aspergillus) for that species was also incubated to act as a positive control and a sample with no 
aptamer as a negative control. Each aptamer was tested twice and the results averaged, and 
standard error expressed as error bars on each graph. Figure 7 shows the concentration of aptamer 






























































Figure 3.7 Average binding of identified aptamers against C. albicans at 4°C and room 
temperature. 200nM of each identified aptamer was incubated with C. albicans for 30 minutes either at room 
temperature or 4°C, and bound aptamers eluted. Eluted aptamers were amplified by PCR using aptfor and aptrev primers, 
before being analysed on a 2% agarose gel using a BioRad ChemiDoc XRS+ system with a 500ms exposure. The 
concentration of amplified aptamer was measured by comparison to a sample of aptamer at a concentration of 171ng/µl. 
Intensity of the band of DNA was measured by BioRad Image Lab software, and compared to the sample of known 
concentration to determine the amount of DNA in each band. Repeated twice. Control was a sample of cells incubated 











Aptamers selected at 4°C for C. albicans showed recovery of varied concentrations of aptamer 
following amplification. Shown in figure 3.7, Ca4B showed the highest concentration following 
incubation at both at 4oC, 15ng/µl, and room temperature, 10.7ng/µl. Ca4A yielded 10.1ng/µl at 4°C 
and 7.9ng/µl at room temperature and Ca4C showed the lowest concentration with 8.9ng/µl at 4°C 
and 4.7ng/µl at room temperature. In all cases, the higher level of binding at 4oC aligns with the 
selection conditions for these aptamers. Those aptamers selected at room temperature, showed 
little difference in binding when selected against C. albicans at either temperature, CaRTA resulted 
in a concentration of 3.6ng/µl at 4°C and 3.ng/µl at room temperature and CaRTB 8.3ng/µl at 4°C 
and 8.6ng/µl at room temperature. Overall, binding of the aptamers selected against C. albicans at 
4oC was higher than those at room temperature. The 4oC selected aptamers, AF4A and Af4B, both 
showed binding to C.albicans cells at both temperatures. Concentrations of these aptamers 
following PCR were 10.5ng/µl (4oC) and 7.7ng/µl (RT) for Af4A and 12.1 ng/µl (4oC) and 10.7ng/µl 
(RT) for Af4B. These were similar levels as seen with Ca4A, Ca4B and CaRTB specifically selected 
against C. albicans. For those A. fumigatus aptamers selected at room temperature, AfRTA showed 
limited binding to C. albicans cells, however, AfRTB (10.7ng/µl – 4oC and 6ng/µl – RT) and AfRTD 
(9.7ng/µl – 4oC and 7.1ng/µl – RT) showed similar levels to the C.albicans specific aptamers Ca4A, 
Ca4C and CaRTB. Aptamers selected against A. fumigatus at 4°C showed similar yields to aptamers 
selected against C. albicans at 4°C, with a yield of 10.5ng/µl for Af4A at 4°C and 7.7ng/µl at room 
temperature and for Af4B, 12.1ng/µl at 4°C and 10.7ng/µl at room temperature. AfRTA yields the 
least amount of aptamer with 3.4ng/µl at 4°C and 3.6ng/µl at room temperature, whereas AfRTB 
(10.7ng/µl at 4°C and 6ng/µl at room temperature) and AfRTD (9.7ng/µl at 4°C and 7.1ng/µl at room 
temperature) show yields more consistent with most other aptamers. As with the C. albicans 
selected aptamers; higher concentrations of A. fumigatus aptamer was consistently seen when cells 
were incubated at 4oC, suggesting better affinity for the target. In all cases, the positive control 




Figure 3.8 shows the concentration of aptamer in a PCR from a sample of elution following aptamer 
incubation with A. fumigatus. The aptamers selected against A. fumigatus AfRTB (16.854ng/µl at 4°C 
and 15.611ng/µl at room temperature) and AfRTD (12.998ng/µl at 4°C and 11.217ng/µl at room 
temperature) showed the best levels of biding for this condition with the levels of binding from 
AfRTB the most comparable to the control Af20. AfRTA only yielded 5.502ng/µl and 4°C and 
6.324ng/µl at room temperature. A. fumigatus selected aptamers at room temperature exhibited 
lower levels of binding than at 4°C (Af4A 10.464ng/µl at 4°C and 9.126ng/µl at room temperature. 
Af4B 9.927ng/µl at 4°C and 9.226ng/µl at room temperature) but better levels of binding than 
AfRTA. Aptamers selected against C. albicans at 4°C exhibited levels on binding similar to that of 
aptamers selected against A. fumigatus in either temperature condition. Ca4A yielded 11.165ng/µl 
at 4°C and 12.149ng/µl at room temperature, Ca4B yielded 7.686ng/µl at 4°C and 10.048ng/µl at 
room temperature and Ca4C yielded 9.215ng/µl at 4°C and 6.12ng/µl at room temperature following 
incubation with A. fumigatus. C. albicans aptamers selected at room temperature exhibited the 
overall lowest levels of binding to A. fumigatus with CaRTA as the lowest (3.363ng/µl at 4°C and 
1.308ng/µl at room temperature) and CaRTB (4.834ng/µl at 4°C and 7.149ng/µl at room 

































































Figure 3.8. Average binding of identified aptamers against A. fumigatus at 4°C and room 
temperature. 200nM of each identified aptamer was incubated with A. fumigatus for 30 minutes either at room 
temperature or 4°C, and bound aptamers eluted. Eluted aptamers were amplified by PCR using aptfor and aptrev primers, 
before being analysed on a 2% agarose gel using a BioRad ChemiDoc XRS+ system with a 500ms exposure. The 
concentration of amplified aptamer was measured by comparison to a sample of aptamer at a concentration of 171ng/µl. 
Intensity of the band of DNA was measured by BioRad Image Lab software, and compared to the sample of known 
concentration to determine the amount of DNA in each band. Repeated twice. Control was a sample of cells incubated 











Across both figures 3.7 and 3.8 there is little difference between the binding of aptamers at 4°C and 
room temperature regardless of which condition they were selected in. However, there are marked 
differences between the binding of certain aptamers in A. fumigatus and C. albicans. Aptamers 
selected against C. albicans Ca4B showed the highest concentration following incubation at both at 
4oC, 15.081ng/µl, and room temperature, 10.772ng/µl in C. albicans but a concentration of 
7.686ng/µl at 4°C and 10.048ng/µ incubated with A. fumigatus. Ca4A (C. albicans 10.071ng/µl at 4°C 
and 7.960 ng/µl at room temperature and A. fumigatus 11.165ng/µl at 4°C and 12.149ng/µl at room 
temperature) and Ca4C (8.904 ng/µl at 4°C and 4.715 ng/µl at room temperature and A. fumigatus 
9.215ng/µl at 4°C and 6.12ng/µl at room temperature) show less affinity for C. albicans. For 
aptamers selected against C. albicans at room temperature there were lower levels of binding 
overall in addition to the lack of specificity (CaRTA C. albicans - 3.633 ng/µl at 4°C and 3.049 ng/µl at 
room temperature, A. fumigatus - 3.363ng/µl at 4°C and 1.308ng/µl at room temperature. CaRTB C. 
albicans - 8.341 ng/µl at 4°C and 8.649 ng/µl at room temperature and A. fumigatus - 4.834ng/µl at 
4°C and 7.149ng/µl at room temperature). Aptamers that were selected against A. fumigatus at 4°C 
showed similarly low levels of specificity with Af4B (C. albicans - 10.466ng/µl  at 4oC and 7.732ng/µl 
at room temperature and A. fumigatus - 9.927ng/µl at 4°C and 9.226ng/µl at room temperature)  
and Af4A  incubated with C. albicans - 12.069 ng/µl at 4oC and 10.686ng/µl at room temperature and 
A. fumigatus - 10.464ng/µl at 4°C and 9.126ng/µl at room temperature) and consistent levels of 
binding. The most promising levels of specificity were exhibited by AfRTB (10.656ng/µl – 4oC and 
5.951ng/µl – room temperature in C. albicans but 16.854ng/µl at 4°C and 15.611ng/µl at room 
temperature in A. fumigatus) followed by AfRTD (C. albicans - 9.738ng/µl at 4oC and 7.066ng/µl at 
room temperature and A. fumigatus - 12.998ng/µl at 4°C and 11.217ng/µl at room temperature). 
AfRTA however exhibited a low level of binding over all along with low specificity (C. albicans - 
5.502ng/µl at 4°C and 6.324ng/µl at room temperature and A. fumigatus - 5.502ng/µl and 4°C and 




3.5 Further Testing of Shortlisted Aptamers 
Aptamers shortlisted for further testing were AfRTB and Ca4B with results indicating that these were 
one aptamer for each species that exhibited the most promising specificity and levels of binding. 
Shortlisted aptamers were further tested by determining their kd through testing binding levels from 
initial aptamer concentrations of 200nM, 100nM, 50nM and 25nM. This is to determine their affinity 

















Figure 3.9. Binding of Aptamers, AfRTB and Ca4B, to C. albicans at a Variety of Concentrations. (A). 
Eluted aptamer, amplified by PCR (B) Binding Affinity of aptamer. Identified aptamers AfRTB and Ca4B 
were both incubated with C. albicans at a concentration of 200nM, 100nM, 50nM, and 25nM for 30minutes at room 
temperature. Aptamers were then eluted. These eluted aptamers were amplified by PCR using aptfor and aptrev primers, 
before being analysed on a 2% agarose gel using a BioRad ChemiDoc XRS+ system with a 500ms exposure. The 
concentration of amplified aptamer was measured by comparison to a sample of aptamer at a concentration of 171ng/µl. 
Intensity of the band of DNA was measured by BioRad Image Lab software, and compared to the sample of known 















































































Figure 3.10. Binding of Aptamers, AfRTB and Ca4B, to A. fumigatus at a Variety of Concentration. 
(A) Eluted aptamer, amplified by PCR (B) Binding Affinity of aptamer Identified aptamers AfRTB and Ca4B 
were both incubated with A. fumigatus at a concentration of 200nM, 100nM, 50nM, and 25nM for 30minutes at room 
temperature. Aptamers were then eluted. These eluted aptamers were amplified by PCR using aptfor and aptrev primers, 
before being analysed on a 2% agarose gel using a BioRad ChemiDoc XRS+ system with a 500ms exposure. The 
concentration of amplified aptamer was measured by comparison to a sample of aptamer at a concentration of 171ng/µl. 
Intensity of the band of DNA was measured by BioRad Image Lab software, and compared to the sample of known 
concentration to determine the amount of DNA in each band. 






















































Figure 3.9a shows a difference in the binding of AfRTB and Ca4B to C. albicans following incubation 
with varying concentrations of aptamer. The PCR product from C. albicans incubation with 200nM 
AfRTB  yielded 2.8ng/µl of aptamer, whereas Ca4B incubated with C. albicans yielded 6.4ng/µl. This 
demonstrates a 3 fold increase in binding in C.albicans compared to A. fumigatus. As the 
concentration of AfRTB aptamer decreased, as did the amount of PCR product indicating that less 
aptamer is being isolated from the cells. However, there was still a clear trend of increased binding 
in C. albicans compared to A. fumigatus. Incubation of the aptamer at its lowest concentration of 
25nM still displays the same trend with AfRTB yielding 0.5ng/µl, but Ca4B yielding 1.8ng/µl. The 
graph overall shows that incubation of both aptamers with C. albicans resulted in some degree of 
binding. However, Ca4B appears to show a much higher affinity for C. albicans, the target it was 
selected against with a Kd of 87.3nM whereas AfRTB has a Kd of 123.3nM.   
In comparison, when AfRTB was incubated with its target cell (A. fumigatus), Figure 3.10, a higher 
level of binding was observed. 200nM of AfRTB incubated with A. fumigatus resulted in a 
concentration of 15.389ng/µl, this is in contrast to C. albicans where there was a 3 fold reduction in 
binding (Figure 9A) Decreasing the concentration of AfRTB to 100nM resulted in a similar 
concentration of aptamer being retained on the target cells. As the concentration of AfRTB reduced 
to 25nM, amplification of the aptamer from A. fumigatus was reduced to approximately 4.3ng/µl. A 
similar reduction trend was also seen in the levels of Ca4B bound to A. fumigatus. From this data the 
Kd of the aptamers was determined in A. fumigatus, with AfRTB showing a lower Kd 81.78nM with 
Ca4B showing a Kd of 93.43nM (Figure 9B). 
Comparison of the Kd of the aptamers from each experiment (table 3.1), indicates that there is a 
clear difference between binding of each aptamer to their target. In C.albicans the Ca4B aptamer 
has a much lower Kd (87.3nM) than is seen in A. fumigatus (123.3nM), indicating a higher affinity for 
C.albicans. A similar trend is seen with the AfRTB aptamer when incubated with A. fumigatus 




Fungal species Kd of Aptamer (nM) 
Ca4B AfRTB 
C. albicans 87.3 93.4 
A. fumigatus 123.3 81.8 
 
Table 3.1 Summary of kd of shortlisted aptamers against each target cell. Ca4B and AfRTB were both 
incubated with both C. albicans and A. fumigatus at different concentrations. The table summarises data from figures 8B 
and 9B. 
However, when comparing the results from figure 8 and 9, as previously observed, the overall level 
of aptamer binding is reduced in C. albicans compared to A. fumigatus, i.e. the highest level of 
binding in C. albicans was approx. 6ng/µl compared with 15ng/µl in A. fumigatus. In regards to Ca4B, 
this means the level of binding seen with the aptamer in C.albicans is similar to that in A. fumigatus.  
For example, at 200nM the concentration of aptamer obtained from C. albicans is 6.5ng/µl and in A. 
fumigatus it is 4.5ng/µl. This may mean that it would be difficult to identify C. albicans using the 
Ca4B aptamer within  a mixed culture of both fungi, due to level of binding of this aptamer to both 
species, you would be unable to distinguish between them.  
3.6 Fluorescence Microscopy 
An alternatively way to determine binding of an aptamer to a target cell is visually with a microscopy 
using a fluorescently tagged aptamer. Both Ca4B and AfRTB were fluorescently tagged at the 5’ end 
with Cy5 by PCR. After incubating 200nM of the tagged aptamers with both C. albicans and A. 
fumigatus, the cells were fixed, and mounted on slides with Vectashield mountant containing DAPI 
counterstain. These were then visualised using a Zeiss fluorescent microscope. Representative 




















Figure 3.11. Cy5 labelled AfRTB incubated with A. fumigatus and C. albicans. Shortlisted aptamer 
AfRTB labelled with Cy5 fluorescent tag (IDT, UK) was incubated with A. fumigatus and C. albicans 
for 30 minutes at room temperature using an aptamer concentration of 200nM. Cells were fixed in 
3.7% formaldehyde and washed with 1x PBS, before being resuspended in vectashield with DAPI for 
mounting onto slides. Slides were imaged using Ziess fluorescent microscope, using a DAPI, Cy5 and 




                                  












Figure 3.12. Cy5 labelled Ca4B incubated with A. fumigatus and C. albicans. Shortlisted aptamer Ca4B labelled with Cy5 fluorescent tag (IDT, UK) was 
incubated with A. fumigatus and C. albicans at room temperature for 30minutes at a concentration of 200nM. Cells were fixed in 3.7% formaldehyde and 
washed with 1x PBS before being resuspended in vectashield with DAPI for mounting onto slides. Slides were imaged using Zeiss fluorescent microscope, 
with DAPI, Cy5 and brightfield filters for an exposure of 1.2 seconds. 
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Figure 3.11 shows faint staining of A. fumigatus with AfRTB within the Cy5 channel, with no 
fluorescence observed in C. albicans. The data seems to suggest binding of AfRTB to its target cell 
and supports the PCR results (Figures 8A and 8B).  
Figure 3.12 shows Cy5 bound Ca4B incubated with C. albicans, which seems to indicate no binding. 
However, when incubated with A. fumigatus, several areas of intense fluorescence were observed 
which corresponded with clumping of the cells.  The PCR data suggested that Ca4B was able to bind 
to both cells types, but with more specificity to C. albicans. This result is not supported by the 
fluorescence data.  
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3.7 Characterisation of previously Identified Aptamers. 
A set of 14 novel aptamers had been previous isolated in the lab against several fungal species. 
Sixteen rounds of SELEX were undertaken at 4°C against A. fumigatus, C. albicans and 
Saccharomyces cerevisiae (S. cerevisiae) using HeLa cells as a negative selection. These aptamers had 
yet to be characterised, so were investigated as part of this study. 
Initially, each sequence was analysed, without the primer sequences, through Clustal Omega 
analysis software. The analysis from this software shows the similarities between the aptamers 
allowing for sequence comparisons. Sequences, with the primer sequences, were also analysed by 
Mfold analysis software to predict secondary folding structure of each aptamer, which is important 










C9269         -------------CCGGGGACGCACCGCATTCAACACGTCGCGAGCACCGCATCA----- 42 
A21279        -------CGTACCACCACACGCCCCGACCATTC---------------AGCATCCGCACC 38 
A20279B       -------CGTACCACCACACGCCCCGACCATTC---------------AGCATCCGCACC 38 
A202710       ---------CCGCGCCAGCACACCACA---------CAGCCATTACCCGGAACCCGTCAC 42 
Af021810      ------------------CACAGCGCACACTACCCAACGCCACACACCTGGACCCCCCC- 41 
Af031810      TCACCGCTC------------TCCCCACGCTTATCCCG----------CTCACCACTCCT 38 
S12709        -----------CCCCGAGTTTACCGCAGAGTTCAGCACACGCCACACTGCCATCCCACAC 49 
S71810        CCACCACTGTCCTTCGAGTTTACCGCAGAATTCGCCGATCCACCACACCTCATCACACCC 60 
C009269       ------CTG--TCGCTGTTT-GCAGTAGCCATGTGTCGTTCTCTCA---GGCTCC----- 43 
C05269        -----CGCG--TCGCTAGTT-GTGTTTGGTTTGTGGTTGTCTTACT---TGGTCT----- 44 
C5269         -----CGCG--TCGCTAGTT-GTGTTTGGTTTGTGGTTGTCTTACT---TGGTCT----- 44 
S8279         --------------CGGTTG-ATGGCACCAGTGTGTCGCCCATTGGC-GGGGTTG----- 39 
Ca28269       ------CTA--CGGACGTCT-TTGCCCTGCGTTCCGCTGCAACTGT---GTGTTC----- 43 
A24279        --------C--CCTACGTGC-GTGGCCGCATTGTGCCTTTTGATGG---GTGTTG----- 41 
                                                                           
 
C9269         -----TTCCGTTCCCC-- 53 
A21279        AGCCTGTCCCTCG----- 51 
A20279B       AGCCTGTCCCTCG----- 51 
A202710       CATCTGTTCGT------- 53 
Af021810      ------------------ 41 
Af031810      CATCTCCCTCCTGCGC-- 54 
S12709        CCTGTCCACCCTGC---- 63 
S71810        CCTCCGTGCC-------- 70 
C009269       -GGGTGTG---------- 50 
C05269        -GTGTGTCCCC------- 54 
C5269         -GTGTGTCCCC------- 54 
S8279         -GATTGTGTCGCGTCCCT 56 
Ca28269       -GTG-CTTCCTTCTCCCT 59 










Figure 3.13.  Analysis of aptamer sequences via Clustal Omega (A) Phylogenetic tree of isolated aptamer. Isolated sequences from the SELEX process were put 
through Clustal Omega software (primer sequences removed) and sequences compared for similarity shown as a phylogenetic tree. (B) Alignment of isolated aptamer 
sequences. Clustal Omega output of sequences aligned. (C) Percentage similarity of all isolated sequences. Clustal Omega output of similarity of sequences 
expressed as percentage values between each sequence.   
Aptamer % Similarity 
 C9269 A21279 A20279B A202710 Af021810 Af031810 S12709 S71810 C009269 C05269 C5269 S8279 Ca28269 A24279 
C9269 100 40 40 43.59 37.84 51.43 39.22 44.69 29.27 25 25 28 32.65 29.55 
A21279 40.00 100 100.00    46.34    42.31    41.03    42.55    47.92    41.67    41.03    41.03    40.54    30.00    40.54 
A20279B 40.00 100 100 46.34    42.31    41.03    42.55    47.92    41.67    41.03    41.03    40.54    30.00    40.54 
A202710 43.59 46.34 46.34   100 59.38    48.39    43.14    50.00    36.84    34.15    34.15    40.00    40.00    25.00 
Af021810 37.84 42.31 100.00    59.38   100 46.43    51.22    46.34    33.33    21.21    21.21    31.43    33.33    12.12 
Af031810 51.43 41.03    41.03    48.39    46.43   100 51.16    56.25    33.33    29.73    29.73    30.77    37.50    27.27 
S12709 39.22 42.55    42.55    43.14    51.22    51.16   100 59.32    38.30    40.00    40.00    30.77    26.92    24.49 
S71810 44.69 47.92    47.92    50.00    46.34    56.25    59.32   100 38.00    33.96    33.96    35.42    29.41    28.57 
C009269 29.27 41.67    41.67    36.84    33.33    33.33    38.30    38.00   100 54.00    54.00    54.55    34.69    36.17 
C05269 25.00 41.03    41.03    34.15    21.21    29.73    40.00    33.96    54.00   100 100   38.30    34.62    32.00 
C5269 25.00 41.03    41.03    34.15    21.21    29.73    40.00    33.96    54.00   100 100 38.30    34.62    32.00 
S8279 28.00 40.54    40.54    40.00    31.43    30.77    30.77    35.42    54.55    38.30    38.30   100 45.28    47.83 
Ca28269 32.65 30.00    30.00    40.00    33.33    37.50    26.92    29.41    34.69    34.62    34.62    45.28   100 46.00 
A24279 29.55 40.54    40.54    25.00    12.12    27.27    24.49    28.57    36.17    32.00    32.00    47.83    46.00   100 
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The phylogenetic tree (figure 3.13A) groups aptamers together based on their similarities in 
sequences. Sequences were grouped into three main families, which may suggest three distinct 
epitopes. The first branch contains 2 aptamers, the second branch contains 10 aptamers and the 
third branch, 2 aptamers. Within the second branch, A21279 and A20279B, have the same 
sequence, as do C05269 and C5269. Further, Ca28269 and A24279 are very closely related as are 
A202710 and Af021810. In the third branch, S12709 and S71810 are closely related to each other.  
Based on the sequence homologue, the majority of aptamers showed less than 60% similarity 
(Figure 12B and 12C).  
 
Figure 3.13B shows the sequence alignments generated by clustal omega, which demonstrates there 
were no conserved regions between all aptamers. However, based on the phylogenetic mapping a 
number of aptamers were found to be closely associated. Therefore, these sequences were analysed 
separately (Figure 3.14).  
 
 
Figure 3.14.  Alignment of isolated aptamer sequences using Clustal Omega. Alignment of two 
aptamers  (A) Ca28269 and A24279 (B) A202710 and Af021810 (C) S12709 and S71810. Conserved 






Based on the phylogenetic tree, the closely related sequences Ca28269 and A24279 showed 22 
consensus bases, with one group of 5 and two groups of 4 conserved bases (Figure 3.14A). A202710 
and Af021810, were also shown to be closely related showing 21 consensus bases, with two group of 
4 and one group of 3 conserved bases. Finally, S12709 and S71810 showed 35 consensus bases, with 
one group of 15 and two groups of 4 conserved bases. 
 
 





























Figure 3.15. Predicted secondary folding structure of previously identified aptamers. All sequences were analysed using Mfold software and folding 
structure predicted based on SELEX conditions (Na+ 137mM and Mg++ 0.25mM) and 4°C. Structures shown are those with the lowest predicted Gibbs free 




Figure 3.15 shows the predicted secondary structures of the previously identified aptamers. The 
predicted folding shows some similarities in structures. With aptamers either showing large loop 
regions, with smaller stem regions or mostly consisting of large stem loop regions.  
3.9 Further Testing of Previously Identified aptamers  
To determine binding of these novel aptamers to different fungal species, 200nM of each aptamer 
was incubated with a different fungal cell type at 4ºC for 30 minutes. The bound aptamer was then 
eluted and used as a template for a PCR. It was assumed that the more aptamer bound to the cell, 
the higher the available template for the PCR, which would result in a higher concentration of the 
final aptamer product. The resulting product was visualised on an agarose gel and quantified using 




























































































Figure 3.16. C. albicans incubated with all previously identified aptamers. C. albicans incubated with all 
previously identified aptamers at a concentration of 200nM, for 30 minutes at 4ºC. Cells were then washed with washing 
buffer, and resuspended in water. Aptamer was then eluted from target cells by heating at 95ºC. A sample of eluted 
aptamer was then amplified by PCR and a sample of the PCR product separated by gel electrophoresis on a 2% agarose gel, 
and visualised by UV light using the ChemDoc XRS+. A sample of known concentration was run alongside the PCR product 
sample and the intensity of each band measured. The concentration of aptamer was calculated by comparison to the 
sample of known concentration (171.1.ng/µl). Each value displayed is an average of 2 repeats, with an amplified aptamer 




 Of the aptamers that were selected against C. albicans there was varying levels of binding when 
incubated with C. albicans, with C5269 (4.6ng/µl), showing the most binding overall. This was 
followed by C05269 (3.8ng/µl), which based on the sequence information is the same sequence. The 
aptamer that appeared to show the lowest level of binding was C9269 (0.5ng/µl). The remaining two 
aptamers showed intermediate levels of binding, C009269 (2.2ng/µl) and Ca28269 (3.3ng/µl).  
Aptamers selected against A. fumigatus when incubated with C. albicans also showed a wide range 
of binding, A21279 (4.2ng/µl) was the highest of these aptamers, followed by A202710 (3.1ng/µl), 
then Af031810 (2.1ng/µl), Af021810 (2.1ng/µl). The lowest levels of binding from this group of 
aptamers were A20279B (0.7ng/µl) and A24279 (0.5ng/µl). The final aptamers incubated with C. 
albicans in figure 3.16 were those selected against S. cerevisiae, again with varied levels of binding. 
S12709 (3.4ng/µl) being the highest, followed by S8279 (3.2ng/µl) and the lowest being S71810 
(1.1ng/µl). 
In most cases, the aptamers selected against S. cerevisiae and A. fumigatus, show significant binding 
to C. albicans when compared to the negative control and the library alone. As previously noted, the 

























































































Figure 3.17. A. fumigatus incubated with all previously identified aptamers. A. fumigatus incubated with 
all previously identified aptamers at a concentration of 200nM, for 30 minutes at 4ºC. Cells were then washed with 
washing buffer, and resuspended in water. Aptamer was then eluted from target cells by heating at 95ºC. A sample of 
eluted aptamer was then amplified by PCR and a sample of the PCR product separated by gel electrophoresis on a 2% 
agarose gel, and visualised by UV light using the ChemDoc XRS+. A sample of known concentration was run alongside the 
PCR product sample and the intensity of each band measured. The concentration of aptamer was calculated by comparison 
to the sample of known concentration (171.1.ng/µl). Each value displayed is an average of 2 repeats, with an amplified 










Figure 3.17 shows the previously identified aptamers now incubated with A. fumigatus. In most 
cases, the binding of the aptamers shows a similar trend as that seen in Figure 3.16 however; 
concentrations of the final aptamer product are consistently higher than seen in C. albicans. 
Aptamers that were selected against A. fumigatus generally show the best yield of aptamer after 
incubation, the highest being A202710 at 9.6ng/µl, followed by A20279 at 9.3ng/µl, then Af031810 
at 6.2ng/µl, A21279 at 5.9ng/µl and the lowest A24279 (4.3ng/µl) and Af021810 at 4.086ng/µl). 
Whereas all aptamers selected against C. albicans generally show much lower yields with Ca28269 at 
3.5ng/µl, followed byC009269 at 3.1ng/µl and the lowest being C9269 at 0.626ng/µl. With the 
exception of C5269 (7.6ng/µl) and C05269 (4.9ng/µl) which exhibited levels of binding more 
comparable to that of Af031810, Af021810 and A24279. Aptamers selected against S. cerevisiae 
show varying yields. S122709 is the highest at 8.4ng/µl followed by S8279 at 6.0ng/µl. S71810 
(1.1ng/µl) was the second lowest from all aptamers. The aptamer library control yielded 1.229ng/µl 
and the no aptamer control 0.111ng/µl. S71810 and C9269 both exhibited binding levels lower than 






























































































Figure 3.18. S. cerevisiae incubated with all previously identified aptamers. S. cerevisiae was incubated 
with all previously identified aptamers at a concentration of 200nM, for 30 minutes at 4ºC. Cells were then washed with 
washing buffer, and resuspended in water. Aptamer was then eluted from target cells by heating at 95ºC. A sample of 
eluted aptamer was then amplified by PCR and a sample of the PCR product separated by gel electrophoresis on a 2% 
agarose gel, and visualised by UV light using ChemiDoc XRS+. A sample of known concentration was run alongside the PCR 
product sample and the intensity of each band measured. The concentration of aptamer was calculated by comparison to 
the sample of known concentration (171.1.ng/µl). Each value displayed is an average of 2 repeats, with an amplified 











Figure 3.18 shows the data for the aptamers incubated with S. cerevisiae cells. Aptamers that were 
selected against C. albicans showed levels of binding similar to their incubation with C. albicans with 
the exception of Ca28269 being considerably higher at 12.2ng/µl. C5269 was the second highest at 
7.2ng/µl, followed by C009269 with 6.075ng/µl, then C9269 at 4.5ng/µl and the lowest being 
C05269 at 3.5ng/µl. Aptamers selected against A. fumigatus had a range of levels of binding, the 
highest being A202710 at 7.9ng/µl, followed by Af031810 at 7.7ng/µl, then A21279 with 7.5ng/µl, 
then Af021810 with 3.9ng/µl and finally the lowest, Af20279B with 3.8ng/µl. Aptamers selected 
against S. cerevisiae also had varied levels of binding. S8279 had the highest level of binding with 
6.5ng/µl, followed by S71810 at 2.6ng/µl and the lowest being S12709 at 0.3ng/µl. 
Comparing these aptamers to their incubation in other species it shows they have some specificity 
fungal species and, in some cases, increased binding to the non-target cell. For example, Ca28269 
was isolated at a concentration of 12.2ng/µl when incubated with S. cerevisiae but at 3 fold less in its 
target fungi, C. albicans(3.7ng/µl) and 4ng/µl with A.fumigatus.. However, a number of aptamers 
were isolated that where specific for their target cell, for example Af20279B gave a yield of 9.4ng/µl 
when incubated with its target fungi, A. fumigatus, but this was significantly reduced in C. albicans 
and(0.5ng/µl( in and, to some extent,  in S. cerevisiae(4ng/µl). Whereas some aptamers bind to all 
the fungal species for example A21279, which bound to all fungi equally well. 
Following on from the results of the PCR assay, five aptamers were short listed that showed some 
specific binding to fungal cells (Table 3.2). These aptamers where C009269 (binding to A. fumigatus 
and S. cerevisiae), Ca28269 (high level of binding to S.cerevisiae), C5269 (binding to C. albicans, A. 
fumigatus and S. cerevisiae), Af20279B (high level of binding to A. fumigatus) and A24279 (binding to 






 Aptamer Binding 
Aptamer C. albicans A. fumigatus S. cerevisiae 
C009269 -   
Ca28269    
C05269    
C5269    
C9269 - -  
A21279    
A20279B -   
S12709   - 
A202710    
Af031810    
Af021810    
S8279    
S71810 - -  
A24279 -  - 
 
Table 3.2 Summary of Aptamer binding to fungal cells. A summary table of all previously identified aptamers 
incubated with C. albicans, A. fumigatus and S. cerevisiae and their level of binding to those species.  indicates 2.5-
4.9ng/µl concentration.  indicates 5.0-7.4ng/µl concentration.  indicates 7.5-9.9ng/µl concentration.  
indicates 10ng/µl and above concentration. 
 
The binding of the short-listed aptamers was further characterised by testing the aptamers at 
varying concentrations (200nM to 25nM) with C. albicans, A. fumigatus and S. cerevisiae cells. This 
would also allow the determination of the Kd, which will help determine their affinity for the target 
cell.  As previously described, following a 30-minute incubation at 4oC with the required aptamer 
concentration, cells where washed and the bound aptamer was eluted. This was then used as the 
template DNA for a PCR. Amplified aptamers were analysed by gel electrophoresis and quantified 




































































Figure 3.19. C. albicans incubated with selected aptamers at differing concentrations. (A) Eluted 
aptamer, amplified by PCR (B) Binding Affinity of aptamer Shortlisted aptamers C009269, Ca28269 and 
C5269 were incubated with C. albicans for 30minutes at a concentration of 200nM, 100nM, 50nM and 25nM. Cells were 
washed with washing buffer, and resuspended in water before bound aptamer was then eluted from target cells. A sample 
of each elution was then amplified by PCR and a sample of this product separated and visualised by gel electrophoresis 
under UV light using ChemiDoc XRS+ on a 2% agarose gel. A sample of known concentration was also run on the same gel 
and the concentration of each sample determined by measuring the visual intensity of each band (using ChemiDoc XRS+ 





Figure 3.19 shows the final concentration of aptamer following incubation with C. albicans of the 
shortlisted aptamers C009269, Ca28269 and C5269 for 30 minutes at 4°C. Ca28269 shows the 
highest concentration of aptamer with a yield of 9.9ng/µl at 200nM and 9.7ng/µl at 100nM 
concentrations. The Kd for this aptamer was determined (calculated from data from figure 18, using 
Graphpad Prism software) to be 117nM. This was much higher than the concentration seen in Figure 
12 when C. albicans was also incubated with 200nM of this Ca28269. As the initial concentration of 
aptamer decreased so did the final concentration; 3.6ng/µl at 50nM and 2.9ng/µl at 25nM. Both 
C009269 (Kd 1.78nM) and C5269 (Kd19.8nM) had less variation in the final aptamer concentration, 
with values staying constant as the initial aptamer concentration decreased. C009269 was the higher 
of the two with concentrations of 6.6ng/µl (200nM) 6.0ng/µl (100nM) 5.8ng/µl (50nM) and 
6.084ng/µl. C5269 gave a yield of 2.5ng/µl at 200nM and 2.5ng/µl 100nM concentrations, 2.2ng/µl 












































































Figure 3.20. A. fumigatus incubated with selected aptamers at differing concentrations. Shortlisted 
aptamers C009269, Ca28269 and C5269 were incubated with A. fumigatus for 30minutes at a concentration of 200nM, 
100nM, 50nM and 25nM. Cells were washed with washing buffer, and resuspended in water before bound aptamer was 
then eluted from target cells. A sample of each elution was then amplified by PCR and a sample of this product separated 
and visualised by gel electrophoresis under UV light using ChemiDoc XRS+ on a 2% agarose gel. A sample of known 
concentration was also run on the same gel and the concentration of each sample determined by measuring the visual 
intensity of each band (using ChemiDoc XRS+ Image lab software) in comparison to the sample of known concentration. 
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Figure 3.20 shows yield of aptamer following incubation with A. fumigatus of the shortlisted 
aptamers C009269, Ca28269 and C5269 for 30 minutes at 4°C. C009269 (Kd 49.78nM) shows the 
highest yield of aptamer with 6.2ng/µl at a concentration of 200nM and 6.8ng/µl at 100nM, 
dropping to 2.9ng/µl at 50nM and rising to 3.267ng/µl at 25nM. Ca28269 (Kd 11.55) yielded 4.9ng/µl 
at 200nM and 4.654ng/µl at 100nM. The yield then drops to 2.9ng/µl at 50nM and then rises slightly 
to 3.984ng/µl at 25nM. C5269 (Kd 90.01nM) shows the lowest overall yield as it did in figure 3.19, 


















































































Figure 3.21. S. cerevisiae incubated with selected aptamers at different concentrations. (A) Binding 
Affinity of aptamer (B) Eluted aptamer, amplified by PCR. Shortlisted aptamers C009269, Ca28269 and 
C5269 were incubated with S. cerevisae for 30minutes at a concentration of 200nM, 100nM, 50nM and 25nM. Cells were 
washed with washing buffer, and resuspended in water before bound aptamer was then eluted from target cells. A sample 
of each elution was then amplified by PCR and a sample of this product separated and visualised by gel electrophoresis 
under UV light using ChemiDoc XRS+ on a 2% agarose gel. A sample of known concentration was also run on the same gel 
and the concentration of each sample determined by measuring the visual intensity of each band (using ChemiDoc XRS+ 







Figure 3.21 shows yield of aptamer following incubation with S. cerevisiae of the shortlisted 
aptamers C009269, Ca28269 and C5269 for 30 minutes at 4°C. Ca28269 shows the best yield of 
aptamer with 9.9ng/µl at 200nM, which stayed consistent with decreasing aptamer concentration 
until 25nM, when the yield dropped to 2.7ng/µl. C009269 and C5269 both have relatively low yields 
with C009269 at approximately 2.0ng/µl at both 200nM and100nM, before dropping to 1.3ng/µl at 
50nM and then 0.576ng/µl at 25nM. A similar trend was observed with C5269, with a maximum 

















































































Figure 3.22. C. albicans incubated with selected aptamers at differing concentrations. (A) Binding 
Affinity of aptamer (B) Eluted aptamer, amplified by PCR. Shortlisted aptamers Af20279B and A24279 were 
incubated with C. albicans for 30minutes at a concentration of 200nM, 100nM, 50nM and 25nM. Cells were washed with 
washing buffer, and resuspended in water before bound aptamer was then eluted from target cells. A sample of each 
elution was then amplified by PCR and a sample of this product separated and visualised by gel electrophoresis under UV 
light using ChemiDoc XRS+ on a 2% agarose gel. A sample of known concentration was also run on the same gel and the 
concentration of each sample determined by measuring the visual intensity of each band (using ChemiDoc XRS+ Image lab 









Figure 3.22 shows the yields of aptamer obtained from the incubation of Af20279B and A24279 with 
C. albicans for 30minutes at 4°C. Af20279B shows a higher yield compared to A24279 with 3.6ng/µl 
at 200nM, which reduced and plateaued at 50nM to 31.9ng/µl. A24279 gave a much lower yield of 
















































































Figure 3.23. A. fumigatus incubated with selected aptamers at differing concentrations. (A) 
Binding Affinity of aptamer (B) Eluted aptamer, amplified by PCR Shortlisted aptamers Af20279B and 
A24279 were incubated with A. fumigatus for 30minutes at a concentration of 200nM, 100nM, 50nM and 25nM. Cells 
were washed with washing buffer, and resuspended in water before bound aptamer was then eluted from target cells. A 
sample of each elution was then amplified by PCR and a sample of this product separated and visualised by gel 
electrophoresis under UV light using ChemiDoc XRS+ on a 2% agarose gel. A sample of known concentration was also run 
on the same gel and the concentration of each sample determined by measuring the visual intensity of each band (using 









Figure 3.23 shows the yield of aptamer following incubation of Af20279B and A24279 with A. 
fumigatus for 30minutes at 4°C. Af20279B exhibits the best binding of any of the aptamers selected 
for further testing for its selected cell type. At 200nM the concentration following incubation was 
25.069ng/µl, which reduced slightly at 100nM (17.612ng/µl), before reaching a plateau. Aptamer 



















































































Figure 3.24. S. cerevisiae incubated with selected aptamers at differing concentrations. (A) Binding 
Affinity of aptamer (B) Eluted aptamer, amplified by PCR. Shortlisted aptamers Af20279B and A24279 were 
incubated with S. cerevisiae for 30minutes at a concentration of 200nM, 100nM, 50nM and 25nM. Cells were washed with 
washing buffer, and resuspended in water before bound aptamer was then eluted from target cells. A sample of each 
elution was then amplified by PCR and a sample of this product separated and visualised by gel electrophoresis under UV 
light using ChemiDoc XRS+ on a 2% agarose gel. A sample of known concentration was also run on the same gel and the 
concentration of each sample determined by measuring the visual intensity of each band (using ChemiDoc XRS+ Image lab 






Figure 3.24 shows the binding affinity of Af20279B and A24279 to S. cerevisiae. Af20279B shows the 
highest binding affinity, but this is still considerably lower than in A. fumigatus with 2.9ng/µl at 
200nM. . As the concentration decreased below 100nM, the level of binding also reduced until it 
reached 1.5ng/µl at 25nM. A24279 showed slightly less binding affinity with 2.4ng/µl at 200nM, 




Aptamer Kd of Aptamer (nM) 
C. albicans  A. fumigatus S. cerevisiae 
Ca009269 1.78 49.78 67.92 
Ca28269 117 11.5 38.82 
C5269 19.8 90.01 65.92 
Af20279B 38.04 10.84 31.92 
A24279 7.95 32.98 284.5 
Table 3.3 A summary of the kd of all shortlisted aptamers against each target cell. Each kd was 
calculated following incubation of each aptamer with each target cell at 200nM, 100nM, 50nM and 
25nM. This tables summarises data from figures  
 
Table 3.3 shows a summary of the kd of all shortlisted aptamers against each target cell. 
Following the high levels of specificity seen in Af20279 (in figures 3.22, 3.23 and 3.24) the binding 
affinity was then assessed visually by fluorescence microscopy. 
3.10 Confirmation of binding of shortlisted aptamers by fluorescence microscopy 
 A sample of Af20279 was ordered tagged with alexa488, cells were then incubated with each target 
for 30minutes using an aptamer concentration of 200nM. Aptamers were not eluted following 
incubation, and cells were washed and fixed in formaldehyde and mounted onto slides using 
Vectashield. Slides were then imaged using Ziess fluorescence microscope, with a 1.2 second 




Figure 3.25.  Af20279 tagged with Alexa488 and viewed by fluorescence microscopy. Shortlisted aptamer Af20279 labelled with Alex488 fluorescent tag 
(IDT, UK) was incubated with A. fumigatus and C. albicans for 30 minutes at room temperature using an aptamer concentration of 200nM. Cells were fixed 
in 3.7% formaldehyde and washed with 1x PBS, before being resuspended in vectashield with DAPI for mounting onto slides. Slides were imaged using Ziess 





























Figure 3.26 Counts of fluorescent/ non-fluorescent cells of each microbial species when 
incubated with Af20279 tagged with Alexa488.  
 
The results in Figure 3.25, show an increased fluorescence in the Alex488 channel when A. 
fumagatius cells are incubated with this aptamer. This fluorescence is not observed in either of 
the other two fungal species, C. albicans or S. cerevisiae, indicating that this aptamer appears 
to be species specific. This supports the data obtained from the PCR experiments.  This data is 
supported by a cell count that was performed, on this set of slides and another (figure 3.26).   
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3.11 Outcome of Negative Selections 
 
 
Figure 3.27. Shortlisted aptamers incubated with HeLa cells. Each shortlisted aptamer was incubated 
with HeLa cells for 1 hour at room temperature at concentrations of 400nM, 200nM and 100nM. Samples of elution 
were taken and amplified by PCR, samples of PCR product were then run on a 2% agarose gel by gel electrophoresis. 
Gels were then viwed under UV light and images taken by ChemiDoc XRS+ image lab software.  
 
Figure 3.27 shows all shortlisted aptamers (A20279, C5269, C28279, C009269, A242710 Ca4B 
and AfRTB) incubated with HeLa cells to confirm whether any binding to HeLa cells takes place. 
Each aptamer was incubated for 1 hour at concentrations of 400nM, 200nM and 100nM with 
HeLa cells. A sample of aptamer library was used as a positive control.  No samples of aptamer 





























The aim of this study was to find DNA aptamers that selectively bind to the medically 
important fungi, C. albicans and A. fumigatus, as a means of improving both the treatment and 
diagnosis of infection caused by these microbes. Much like the current issues facing 
antibacterial treatments, many fungi are now resistant to known antifungal agents. The class 
of antifungals echinocandins for example have seen reported cases of resistance after just one 
week of treatment (Lewis et al. 2013). There are also specificity issues associated with some 
antifungal drugs, for instance the commonly used amphotericin B targets ergosterol in the cell 
membrane causing depolarisation of the membrane, leakage of intercellular components and 
eventually cell death (Brajtburg et al., 1990). However, amphotericin B exhibits high 
nephrotoxicity (Torrado et al., 2008). Amphotericin B is also capable of binding to cholesterol 
in mammalian cell membranes, which leads to depolarisation of the membrane and leakage of 
intracellular components. The addition of leaked K+ and other intracellular ions into the body 
creates strain on the kidneys to process the excess concentration in the blood in addition to 
this the cells membranes of nephrons are particularly rich in sterols meaning that the effects of 
amphotericin B are exaggerated in kidney cells. These adverse effects are not limited to one 
class of antifungals, Itraconazole for example was found to have a 23% chance of treatment 
being discontinued due to adverse effects (Wang et al. 2010). The high mortality rate 
associated with invasive fungal infections means that the aggressive side effects are part of a 
necessary treatment, however, there are ways to dramatically improve this. One way in which 
this can be done is through the use of targeting molecules such as DNA aptamers. Their high 
affinity and specificity for a target and their potential for conjugation to drugs means that they 
can be used in conjunction with current treatments to improve the quality of treatment for 
patients, without the need for new drug development. As well as treatments, the slow and 
inefficient means of diagnosis of fungal infections can also be improved with the use of 
aptamer based assays (Drolet, Moon-McDermott and Romig, 1996, Tang et al. 2016) to create 
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point of care testing kits.  Which in turn, lead to faster identification of treatment options and 
better patient prognosis (Barnes, 2008). 
4.1 Optimisation of the SELEX procedure using fungal cells 
The SELEX protocol was adapted from the whole cell SELEX protocol set out by Sefah et al. 
(2010). This is a published standardised method for the selection of any aptamers derived from 
the original aptamer work developed by Tuerk and Gold (1990). An important aspect of SELEX 
is the optimisation of PCR and influences of initial library amplification, in order to ensure 
efficiency throughout (Takahashi et al., 2016). Previous work had shown that amplification of 
the aptamer library using the PCR conditions in this paper, resulted in the formation of primer 
dimers, where primers anneal to each other as opposed to corresponding ends of the template 
sequence. This can also leads to incorrect formation of the template strand, including the 
addition of hairpin loops in the template from the strand folding (Tolle et al., 2014). Changes 
were made to the PCR programme to reduce the production of non-specific DNA amplification 
through the addition of DMSO (Hardjasa et al., 2010) and increase in annealing temperature to 
enhance the specificity of the primers used. DMSO improves amplification of the template in G 
and C rich sequences by lowering the denaturation temperature between G and C reducing the 
formation of primer-dimers and increases the accuracy of template reproduction. The ideal 
concentration of MgCl2 was also optimised to control the folding of template strands during 
PCR.  It is important for the PCR stages of SELEX to be optimised, as aptamer amplification is 
very different to homogenous DNA amplification (Musheev and Krylov, 2006). An important 
aspect of this is the choice of enzyme for PCR. In this case Taq polymerase 
To ensure the sole amplification of aptamers and not non-specific DNA, target cells were 
incubated with no aptamers. These samples were then heated, eluted and centrifuged just as 
the positive selections were and a sample of these put through the same PCR and run on 
agarose gel. These samples needed to be free of any DNA to ensure that non-specific 
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amplification had not occurred. Figures 3.1a and 3.1b and 3.2a and 3.2b, show the positive 
results from each rounds PCR along with negative controls, there is no evidence of 
amplification of non-specific DNA, which suggests the PCR protocol has been optimised for 
amplification of the aptamer sequence.  
4.1.2 Cell SELEX in fungi 
Candida albicans and Aspergillus fumigatus are two of the most prevalent invasive fungi to 
cause infections in humans so this study concentrated on isolating aptamers against these 
microorganisms. 
There are no published papers that detail selection of aptamers against whole cell fungi, 
however, there are many examples of studies describing the selection of aptamers against 
whole cell bacteria. Chen et al. (2007) found aptamers selected against Mycobacterium 
tuberculosis using 108 CFU/ml, decreasing to 105 CFU/ml in later rounds to increase selection 
pressure on the aptamers. Duan et al., 2013 also used 108 CFU/ml of Shigella dysenteraie for 
selection of aptamers. Initially rounds of one round of selection was undertaken with different 
numbers of cells, which resulted in the optimal 3x106 CFU/ml C. albicans and 7.5x106 CFU/ml 
of A. fumigatus for this study. This was found to provide enough target to narrow the aptamer 
pool in the initial SELEX rounds, as seen by the presence of aptamer post incubation from 
round one of selections (Figures 3.1a and b and 3.2a and b).  
In terms of fungi there are studies detailing selection against ideal targets for aptamers like 
Tang et al. (2016) selecting aptamers against fungal cell wall component β 1- 3 D Glucan.  
Purified β -1,3-D glucan was used as the target molecule for rounds of selection. This study 
resulted in aptamers specific to β, 1-3, D glucan, however testing of the aptamer against whole 
cells was not performed in this study. Previous studies have indicated that while using an 
isolated protein as a target is a viable option, there can be problems with the binding of the 
aptamer when the protein is in its native conformation (Pestourie et al., 2006) due to the 
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specific nature of aptamers and the conditions that can affect protein folding. As well as β-1,3- 
glucans being present in all species of fungi, potentially leading to incorrect diagnosis, it is also 
present after some medical procedures. β-1,3- D glucans are present in cellulose membranes 
used in haemodialysis (leading to an increased concentration patient serum (Kanda et al., 
2001) and cotton gauze and sponges used in surgeries (Usami et al., 2002). 
However, aptamers they found with the highest binding affinity were taken forward for use 
testing patient plasma samples by sandwich ELONA (Enzyme linked oligonucleotide assay, 
Drolet, Moon-McDermott and Romig, 1996). The ELONA method was developed for use with 
existing ELISA systems, but with aptamers replacing the antibody component, and is a reliable 
replacement for ELISA (Toh et al., 2015).  An industry example of this is the development of an 
aptamer based assay for the detection of Ochratoxin A, produced by Aspergillus and 
Penicillium spp. that grow on agricultural products. This mycotoxin is highly toxic even at low 
doses, so detection of contamination is very important. Neoventures Biotechnology Inc. 
commercialised a highly sensitive assay for the detection of this mycotoxin that is now 
commercially available (Penner, 2012). Methods like this that utilise the reliable binding 
potential of aptamers make for faster, cheaper and more stable point of care testing, which 
would help to reduce the long diagnostic processes currently used and aid with earlier 
detection and treatment leading to better outcomes for the patient. 
C. albicans is a yeast like fungus that lives, in a budding yeast form, commensally as part of the 
gut biome in most healthy individuals. For the purposes of this study, aptamers were selected 
against the C. albicans yeast like form, as many of the proteins needed for hyphal formation 
are expressed at the cell surface in both hyphal and budding forms. In the case of C. albicans 
infection when C. albicans has formed a biofilm it releases cells in their yeast like form to 
circulate the body and spread the infection. In terms of detection, being able to identify C. 
albicans reliably in a blood test would make for better diagnosis especially because infection is 
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missed in around 50% of sample from blood culture (Ostrosky-Zeichner, 2012). For future work 
it may be beneficial to perform selections of aptamers with C. albicans in its hyphal form. By 
growing C. albicans in it hyphal form more specific aptamers for the infectious stages could be 
isolated and could be useful in the diagnosis of systemic Candida infections within isolated 
tissue samples. 
For A. fumigatus the spores were used for selections as they could be readily re-suspended in 
solution whereas the whole filamentous cell does not re-suspend in solution as readily. A. 
fumigatus grows in its hyphal form once it has been established in a stationary location; 
however with the long incubation time of the spores it is difficult to detect infections before 
they have started. By selecting against the spores this would enable aptamers to be used for 
diagnostic purposes such as on point testing kits that could provide a quick and simple check 
for potential infection in patients that are known to be a high risk for infection.  
Also due to the melanin coating on the cell wall of the spores, they often go undetected by the 
body in at risk patients because of failings in other aspects of the immune response. Other 
studies have detailed the use of aptamer conjugates as a means of improving the bodies non-
specific immune response (Bruno, Carrillo and Phillips, 2008). 
Preliminary rounds of SELEX were performed to optimise the number of C. albicans cells and A. 
fumigatus spores used.  Saccharomyces cerevisiae was used as part of the initial optimisation 
of the SELEX procedure (data not shown) due to its similarities to C. albicans and its wide use 
as a model organism (Karathia et al., 2011). The number of cells used is a key part of 
optimisation, too many cells and the likelihood of selecting aptamers with high levels of 
specificity decreases as cell numbers is a selection pressure, but not enough cells and there 
would not be enough to isolate aptamers from the library as the selection pressures would be 
too high (Spill et al., 2016 and Wang et al., 2012). 
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Diagnosis is not the only issue with patient treatment, high toxicity resulting from non-specific 
action of current antifungal treatments could be reduced with the development of drug 
aptamer conjugates. For instance an aptamer that would bind specifically to ergosterol in the 
cell membrane and not affect cholesterol synthesis in surrounding mammalian tissue would 
greatly improve the efficacy of amphotericin B. Also more specific targeting would reduce the 
necessary dose and also help to reduce the toxicity of amphotericin B. By using whole cell 
SELEX the target of the aptamer is not limited, and the addition of negative selections to 
reduce the number of non-specific aptamers greatly improves the quality of aptamers from 
the final round.  
4.1.3 Temperature as a condition for SELEX in fungal cells. 
Fungi have long been used for the transformation of DNA exhibiting their ability to internalise 
extracellular DNA. Aptamers were selected at 4°C and room temperature. At 4°C cell 
membrane transport processes are inactive (komai et al., 1992) so this limits the 
internalisation of aptamers thus limiting aptamer targets to the cell membrane. Room 
temperature selections were also performed to allow active transport processes to continue 
and aptamers be internalised with the hopes of gaining aptamers that were internalised and 
aptamers with cell membrane targets.  Room temperature selections also served as a more 
real world applicable condition. As diagnostic tests, on blood culture for example, would be 
run at room temperature, having an aptamer that’s binding has been optimised for room 
temperature would make the transition from discovery to application easier. 
Temperature is also important for the folding of aptamers as temperature affects secondary 





4.1.4 Negative Selections in whole cell SELEX 
The addition of a negative selection step in the SELEX process allows aptamers that bind with 
the negative control to be removed from the aptamer library. As suggested by Sefah et al. 
(2010) and carried out by Dwivedi, Smiley and Jaykus, (2013) and Tang et al. (2016). A closely 
related cell type was added and the aptamers that bound to his cell type were removed from 
selections, this improves specificity of aptamers. This was especially critical for this study as 
one of the issues associated with antifungals is their non-specific action affecting human 
tissue. Other aptamer studies have also used a counter selection step to distinguish between 
closely related targets (Cerchia et al., 2009) and to improve the specificity of aptamers to the 
target cell (Moon et al., 2015). HeLa cells were used in this study as a negative selection to 
eliminate binding to mammalian cells. HeLa cells are a well-established and versatile cell line 
used in many branches of research.  
HeLa cells were treated with trypsin to detach them from the surface of the flask to be used 
for selections. Trypsin is a common method for detaching cells from their surface however 
trypsin damages the cell membrane in order to detach cells, so prolonged incubation with 
trypsin causes cell membrane damage, and can affect many of the proteins that are expressed 
on the membrane of the cell (Huang et al., 2010). This can affect the binding of the aptamer as 
using damaged cells for a negative selection might only guarantee no binding to the damaged 
protein. This could mean that, the aptamer could bind to the wild type, expressing a normal 
version of that protein as very subtle changes in structure of the target can differentiate 
between a binding and non-binding aptamer.  10,000 HeLa cells were used in this study, to 





4.1.5 Isolating aptamers against A. fumigatus and C. albicans using cell SELEX 
A total of ten rounds of selections were undertaken for this study. Through each round of 
selection the amount of aptamer amplification is monitored (shown in figures 3.1 and 3.2) to 
show whether amplification of binding aptamers has occurred between rounds. There were 
instances where bands of varying sizes were separated during gel electrophoresis, to eliminate 
the DNA from these bands  and to reduce the amplification of non-specific DNA (Tolle et al., 
2014 and Musheev and Krylov, 2006) a gel extraction was performed (Dwivedi, Smiley and 
Jaykus, 2013) between each round to carry forward amplification of aptamers of the correct 
size.  However there are issues associated with gel extraction, the yield of the desired size DNA 
sample following gel extraction can reduce dramatically (Langridge, Langridge and Bergquist, 
1980). This can be due to the improper melting of the agarose gel, or loss during the many 
washing steps involved with a gel extraction. In future it may be beneficial to limit the number 
of gel extractions performed throughout the selection process, to reduce the potential loss of 
aptamers.  
The apparent decrease in the amount of aptamers through each round could be caused by the 
narrowing of the aptamer pool as each round further excludes non-binding aptamers. 
However, there are variations in each selection, most studies expect to see a decrease in the 
amount of aptamer amplified as the aptamer pool narrows as non-binding aptamers are 
eliminated from the pool. This is expected to then be followed by an increase in PCR product 
concentrations as the binding aptamers remaining in the pool are amplified. A. fumigatus at 
room temperature (figure 3.2b) reflects this pattern the best out of all conditions, and was the 
only condition to produce 4 positive colonies at the cloning stage, and also the only conditions 
to produce 2 of the same sequence, suggesting this condition was more abundant in binding 
aptamers. Figure 3.2a shows the PCR products of rounds of selection in A. fumigatus at 4°C, 
the concentration of PCR product  appears to decline up to round 9, where is suddenly 
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increases. This suggests that the process of narrowing the aptamer pool took more rounds of 
selection in this condition, and that to improve the quality of aptamers gained from this 
condition it would be beneficial to carry out more rounds of selection to allow sufficient 
amplification of binding sequences.  Figures 3.1a and b show selections in C. albicans at both 
temperature selections, these are far more varied and do not seem to show the same pattern 
that figures 3.2a and b show. There are a number of uncertainties during the SELEX procedure, 
one of which is the unexpected loss of aptamers 
4.1.6 Determining levels of aptamer binding 
However other studies use different methods of measuring their post selections amplification. 
Shangguan, Bing and Zhang (2015) used flow cytometry binding assays to determine the levels 
of binding after certain rounds of selection. They also saw a much more consistent level of 
amplification throughout the rounds of selection. Duan et al. (2013) used fluorescence 
intensity as a measure of aptamer binding as part of their second stage testing to calculate the 
Kd for their aptamers. For future work it would be worth considering using fluorescence 
intensity to confirm the viability of the method used and better monitor the amount of 
amplification following each round. 
4.1.7 Isolating aptamers by TOPO Cloning 
The product from round 10 of each selection condition was amplified by PCR as previously 
described and then cloned into a TOPO vector. These vectors were then transformed in 
chemically competent E. coli and grown. Only 11 colonies in total were obtained from all four 
selection conditions, considerably less than expected. This may have been due to the fact that 
the TOPO vector relies on an A overhang on the end of each sequence which must be added 
post PCR. A different vector like JetClone could have been used which relies on blunt ends, and 




4.2 Characterisation of isolated aptamers 
4.2.1 Sequencing of isolated aptamers 
The primary structure of DNA is made up of a series of nucleotides, the sequence of which is 
important for folding and, therefore, binding of the aptamer to its target.  
The isolated aptamers, obtained following cloning from SELEX round 10 of, were sent for 
sequencing. The sequences were then analysed through the Clustal Omega software (with 
primer sequences removed) and an output of percentage similarities between each sequence 
was analysed. 
The phylogenetic tree (figure 3.4a) groups the sequences into three main families, suggesting 
three distinct epitopes. Aptamers that were selected at the same temperature appear to be 
more closely related than aptamer that were selected against the same species. Within the 
first branch, AFRTD and CARTA are more closely related, as are CA4A and AF4B, than CaRTA to 
Ca4A or AfRTD to Af4B. In the third branch, CA4C and CA4B are closely related to each other 
than AFRTA.  
For instance aptamers Ca4B and Ca4C share 53.85% similarity whereas between other 
aptamers from C. albicans at 4°C it is below 35%. Between conditions, within C. albicans varies 
again with the highest homologue being between Ca4A and CaRTB at 47.17% and the lowest 
Ca4C and CaRTA at 15.69%. For A. fumigtus sequences AfRTB and AfRTC were found to be the 
same sequence implying that this sequence was more abundant following isolation against this 
condition. These sequences also had their own distinct epitope in figure 4a, meaning they are 
not closely related to any of the other aptamers.  
Sequences were also aligned by Clustal Omega to show any conserved regions between 
aptamers, as this may indicate whether aptamers share similar targets or whether there are 
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regions of aptamers that are important for binding.  The aptamers indicated to be closely 
related by the phylogenetic tree (figure 3.4a) were aligned, AfRTD and CaRTA showed a total of 
32 consensus bases, with one group six, one group of five and two groups of four.  CA4A and 
AF4B, were also shown to be closely related showing 26 consensus bases, with one group of 5 
and one group of 4 conserved bases. Finally, CA4C and CA4B showed 25 consensus bases, with 
one group of 5 conserved bases. 
4.2.2 Secondary Structure of isolated aptamers 
Secondary structure was predicted using Mfold software, as this can indicate key regions of 
aptamers for binding.  Conditions set for folding were based on the ion concentration dictated 
by the binding buffer used during incubation of aptamers and target cells, as the folding during 
incubation heavily influences the aptamers binding ability. Mg++ concentration was 0.25mM in 
binding buffer. Hamula et al. (2008) used a binding buffer with 1mM Mg++, this study opted for 
a much lower concentration as aptamers with a higher binding affinity rely less on Mg++ 
concentration (Carothers et al., 2010). Predicted secondary structure has been used to identify 
specific regions of aptamers, key for binding, based on the comparison of several aptamers 
secondary structures (Mei et al., 2012). These predictions have also been used in the 
modification of identified aptamers to improve binding.  Kaur and Yung (2012), after 
determining the structure of an aptamer against VEGF165, truncated stem loop regions of the 
aptamer and found that a truncation of one of the stem loop regions led to a dramatic increase 
in binding affinity of the aptamer. However, tertiary structure is also important for aptamer 
binding (Wang et al., 1993) as many targets are complex three dimensional structures, 
aptamers must fold to fit these structures for better binding affinity (Choi and Ban, 2016). 
The predicted structures of identified aptamers vary considerably in similarity. Figure 4a shows 
aptamers selected against C. albicans at 4°C, Ca4A and Ca4B show similarities in predicted 
folding, with both aptamers having predicted stem loop structures which have been shown to 
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be important for aptamer binding (Kaur and Yung 2012). For aptamers selected against C. 
albicans at room temperature there is less stem structures than seen in the 4°C aptamers, with 
larger loop regions comprising the main structure. The aptamers selected at 4°C in C. albicans 
share more similarities in structure with aptamers selected at 4°C in A. fumigatus, with these 
aptamers also containing more stem regions. Aptamers selected against A. fumigatus at room 
temperature show the largest loop regions of all of the structures, but bearing most similarity 
to C. albicans at room temperature aptamers.  
4.2.3 Characterisation of Identified Aptamers 
All identified aptamers were further tested in both temperature conditions and against each 
target cell. Incubation time was reduced from 1 hour to 30minutes to increase selective 
pressure (as performed by Meyer et al., 2013). 200nm of each aptamer was incubated with 
both C. albicans and A. fumigatus at 4°C and room temperature. PCR samples from each 
elution was then run on agarose gel and visualised by UV light. To enable quantification of the 
bound aptamer, a sample of aptamer library at a concentration of 171ng/µl was used a 
reference.  
Each aptamer was tested at both room temperature and 4°C despite the selection. When 
testing all aptamers some showed little to no difference between binding levels at 4°C and 
room temperature, CaRTB, AfRTA, CaRTA and Af4B for example in figure 6 all show a 
difference of less that 2ng/µl in aptamer binding between 4°C and room temperature.   
The aptamers with the highest yield following incubation in their target cells, but limited 
product in the opposing cell type, were considered for further testing.  This was determined by 
comparing the yields of aptamers to each other, aptamers were judged based on the levels of 
binding they exhibited between species of targets and also compared to a control of an 
aptamer with known specificity for that species. For instance Ca4A yielded 10ng/µl at 4°C, 
which implies recovery from elution and thus binding to C. albicans, however, when incubated 
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with A. fumigatus yielded 11.2ng/µl showing that this aptamer also binds to A. fumigatus. So 
although this aptamer shows levels of binding, it was not to be tested further as it does not 
exhibit the desired level of specificity.  Aptamers CaRTA and AfRTA showed relatively poor 
binding in both C. albicans and A. fumigatus with a minimum 4 fold decrease in binding 
compared to Af20 and C9. AfRTD and Ca4A showed very little difference in their binding 
between species, both at around 9ng/µl in C. albicans and around 12ng/µl in A. fumigatus. 
Aptamers Af4A and Af4B also followed the same pattern. This may be due to the targets that 
the aptamer has bound to. A common target in fungal cells for antifungals is the cell wall 
component β 1-3 D Glucans and their abundance throughout the cell wall, and non-existence 
in mammalian cells makes them an easy target. It is likely that a lot of the aptamers have this 
as their target or other cell wall components and thus no matter the selection temperature 
were not taken up into the cell meaning they would bind just as well at room temperature 
than 4°C.  
 The aptamers that were taken forward for further testing were AfRTB and Ca4B. AfRTB 
showed promising amounts of specificity to A. fumigatus with a yield of only 5.9ng/µl after 
incubation with C. albicans but a near threefold increase in binding after incubation with A. 
fumigatus. This was also the most comparable to the control aptamer Af20 which 19ng/µl at 
room temperature and was also the highest yield from aptamers incubated with A. fumigatus.  
Ca4B was also selected because of its promising specificity for C. albicans, yielding 7.6ng/µl 
after incubation with A. fumigatus at 4°C but yielding double that (15ng/µl) after incubation 
with C. albicans. Despite the control aptamer C9 exhibiting double the levels of binding this 
Ca4B showed the best levels of specificity in comparison to other identified aptamers selected 





4.2.4 Further Testing of Selected Aptamer 
Aptamers that showed the most specificity and affinity in binding by PCR were selected to 
move forward to further testing. Aptamers were tested at different concentrations to 
determine the limitations of their binding, allowing the Kd for each aptamer to be calculated. 
The Kd (disassociation constant) represents the concentration of a ligand that binds to half of 
the receptor population. In this case, half the concentration of aptamer required to bind to all 
of its targets. By testing the binding of the isolated aptamers at 200nM, 100nM, 50nM and 
25nM a pattern of binding potential can be determined and the kd calculated. In this instance 
kd was calculated using Graphpad Prism software, from the determined concentration of 
aptamer in each band of DNA following elution and PCR (as described in section 4.2.3). The kd 
could have been calculated using fluorescence intensity. An aptamer tagged with a fluorescent 
molecule, incubated with target cells and processed by flow cytometry would mean a larger 
number of cells could be processed, at a larger number of different aptamer concentrations 
and a more accurate representation of binding in the target gained. 
Each of the aptamers shortlisted for further testing were incubated with HeLa cells for 1 hour 
at concentrations of 400nm, 200nm and 100nm. Covering a range of concentrations both 
above and below the selection concentration and incubating aptamers with HeLa cells for 
longer meant that the conditions for aptamers to potentially bind were favourable. However 
no binding occurred of the aptamers to HeLa cells indicating the effectiveness of the use of a 
negative selection. Although only on one cell line, shows the potential use of aptamers as a 
means of clearly distinguishing between fungal cells components and their similar mammalian 
counterparts.  
4.3 Visualisation of Binding 
Binding was visualised by use of fluorescence microscopy. Aptamers were conjugated with 
either Alexa488 or Cy5 fluorescence molecule and the SELEX protocol carried out as previously 
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described without removal of the aptamer from target cells. Cells were then fixed with 
formaldehyde and mounted on slides with Vectasheild.  
 Figure 10 shows very faint fluorescence AfRTB tagged with Cy5 in A. fumigatus, with no 
fluorescence observed in  C. albicans. The data seems to suggest binding of AfRTB to its target 
cell and supports the PCR results (Figures 8A and 8B). However it is very faint, and  
Figure 11 shows Cy5 bound Ca4B incubated with C. albicans, which seems to indicate no 
binding. However, when incubated with A. fumigatus, several areas of intense fluorescence 
were observed which corresponded with clumping of the cells.  The PCR data suggested that 
Ca4B was able to bind to both cells types, but with more specificity to C. albicans. This result is 
not supported by the fluorescence data.  This image when viewed with DAPI stain and 
brightfield, appears to shows a large clump of A. fumigatus cells, a mixture of spores and the 
hyphae. Before use, spores of A. fumigatus were cultivated by loop transfer from an SAB agar 
plate, washed, and vortexed to ensure free suspension of the spores. However, it is possible 
that in this process, an amount of hyphal cells were inadvertently included in transfer. These 
hyphal cells are very difficult to separate, so it is likely that they would maintain this structure 
even with rigorous vortexing. The images are representative of this set of data and a repeat, 
where the same results were observed. Controls with no aptamer were imaged to account for 
and remove background fluorescence.   
4.4 Future Improvements 
The selected aptamers show some specificity but this is limited. A potential solution to this 
would be to include each of the other cell types as negative selections. As done by Bachtiar, 
Srisawat and Bachtiar, (2019) who used S. cerevisiae as a counter selection. This study would 
benefit from the use of the same, using S. cerevisiae as a counter selection for C. albicans and 
also A. fumigatus. This would improve the specificity issues between species. 
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4.5.1 Characterisation of Previously Identified Aptamers 
A set of 14 aptamers had been previously identified following 16 rounds of selection against A. 
fumigatus, C. albicans and S. cerevisiae at 4°C, with a negative selection against HeLa cells. 
These aptamers hadn’t been characterised, so they were tested to determine their specificity 
to the relevant fungal species. Each aptamer was incubated with each target cell for 30minutes 
before the concentration of the bound aptamer was determined by PCR.  These 
concentrations of aptamer following incubation were compared to the elution concentration 
of aptamer library sample incubated with each cell type. In order for an amount to be 
considered a good level of binding it must be higher than the amount from the aptamer library 
sample to demonstrate the higher abundance of binding sequences. 
4.5.2 Sequencing of Previously Identified Aptamers 
As with the above set of aptamers, this set was sent for sequencing following isolation. The 
phloygenetic tree (figure 12a) suggests three distinct epitopes. Two of the branches containing 
two aptamers each (C9269 and Af031810 together and S12709 and S71810 together) and a 
third branch containing the remaining 10 aptamers, within this Ca28269 and A24279 are very 
closely related, and the sequences A21279 and A20279B are the same, as are C005269 and 
C5269. The sequences grouped as closely related were aligned to highlight any conserved 
regions between them. Based on the phylogenetic tree, the closely related sequences Ca28269 
and A24279 showed 22 consensus bases, with one group of 5 and two groups of 4 conserved 
bases (Figure ?A). A202710 and Af021810, were also shown to be closely related showing 21 
consensus bases, with two group of 4 and one group of 3 conserved bases. Finally, S12709 and 





4.5.3 Secondary structures of previously identified aptamers 
The predicted secondary structures of the previously identified aptamers vary considerably 
regardless of the target cell they were selected against. C. albicans selected aptamers C009269 
and C9269 show a majority of stem loop structures, whilst Ca28269 consists of a larger middle 
loop region with 4 smaller stems. C5269 again shows a middle loop region, but much smaller 
than that of Ca28269 and 4 stem loop structures, with one much longer stem.  S1279 and 
S71810 (both selected against S. cerevisiae) both show long stem regions with small loops. 
When these two sequences were aligned they showed 59% similarity with 35 consensus bases, 
one group of 15 and two groups of four.  However both aptamers did not share consistent 
similarities in binding properties. Incubated with S. cerevisae S12709 yielded the lowest 
aptamer following incubation (0.3ng/µl) and S71810 the second lowest (2.6ng/µl). The 
aptamer library control was 2.3ng/µl, meaning that S71810 is deemed as showing very poor 
binding and S12709 shows poor binding being barely above the control. However, S12709 
shows better levels of binding in C. albicans (3.4ng/µl) and considerably better levels of 
binding in A. fumigatus (8.4ng/µl) whilst S71810 remains below the levels of aptamer library 
control binding for all targets. This could indicate that the consensus bases, more probably the 
larger group of 15 consensus bases (as this would likely have the largest impact on structure) 
could be detrimental to binding of this aptamer to S. cerevisiae. 
Aptamers selected against A. fumigatus appear to show less variation in the predicted 
secondary structure than described in the previous aptamers. All appear to form a large loop in 
the middle, with 4-5 small stem loop structures. With the exception of Af021810, which is 
mainly comprised of a long stem loop region, and a smaller loop, with another stem loop 
region attached.  Af021810 was grouped closely with A202710 on the phylogenetic tree 
(figure12A) and shares 21 consensus bases. As summarised on table 3.2, Af021810, shows less 
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affinity against all target cell types than Af202710, this suggests that the consensus regions 
highlighted are not crucial for binding. 
4.5.4 Binding of previously identified aptamers 
Figure 15 shows all the aptamers tested against C. albicans. The aptamers that were originally 
selected against C. albicans showed relatively low levels of binding compared to the levels of 
binding seen with aptamers selected against A. fumigatus of S. cerevisiae. For example all 
aptamers selected against C. albicans yield less than 5ng/µl, whereas aptamers incubated with 
A. fumigatus range from no binding, to just under 10ng/µl and aptamers incubated with S. 
cerevisiae range from no binding to over 10ng/µl. There is also an abundance of aptamers that 
show degrees of binding across species.  Af021810 and S8279 show similar levels of binding 
across species, whereas C5269 shows binding across species but with even more binding to A. 
fumigatus. As previously mentioned, all species of fungi share the general composition of the 
cell wall and membrane. However there are differences in the levels that these components 
are expressed at.  Chitin for example, represents a relatively low proportion of fungi cell wall, 
however it is far more abundant in S. cerevisiae (Lesage and Bussey, 2006). This could explain 
the binding of Ca28269, where there were relatively low levels of binding in C. albicans and A. 
fumigatus but much higher levels of binding in S. cerevisiae. Chitin is present in the membrane 
of C. albicans and therefore a viable target for aptamer binding during selection. 
Figure 16 shows the binding of all previously identified aptamers against A. fumigatus. As 
previously stated the aptamers incubated showed more varied levels of binding than in C. 
albicans. The aptamers C5269, C05269 and C009269 all showed higher levels of binding affinity 




All of the aptamers incubated with C. albicans for figure 15 appear to have a much lower yield 
than those incubated in A. fumigatus and S. cerevisiae. For instance, C009269 was taken 
forward for further testing, in figure 15 the yield of this aptamer is 2.2ng/µl whereas when 
incubated at a 200nM concentration (figure 15) to determine its Kd the yield was much higher 
at 6.6ng/µl. The same is also true for Ca28269 which yielded 9.867ng/µl in figure 14 compared 
to just 3.1ng/µl in figure 15. Each incubation was repeated twice and controls containing cells 
with no aptamer and aptamer with no cells gave the expected results. This suggests that there 
was no non-specific amplification occurring and that there was sufficient amplification of DNA 
during PCR. This would then leave the inconsistencies to have occurred during incubation.  
There are many points at which error could occur. The amount of aptamer bound to target 
cells was measured by comparing the intensity of visualised PCR samples at the end of each 
round to DNA aptamer of known concentration. This method relies on the elution of all bound 
aptamers from the cell (if not all then a similar percentage of each sample) which was not 
investigated. This could affect yields of aptamer between the same samples. However, the 
same aptamer PCR programme and conditions were used for every PCR so the amplification of 
each sample is kept at a constant.  Also the measuring of each sample was always compared to 
the same sample of known concentration, and was run on every gel. So variations in overall 
intensity of bands on the agarose gel following electrophoresis was accounted for. In addition 
to this, according to other sources 95°C heating followed by centrifugation is sufficient to elute 
enough aptamers to use in subsequent rounds of SELEX (Mozioglu et al., 2015 and Turek, 
2013) so with this assumption the amount of aptamer remaining within the discarded cells 
should not make a large difference to the aptamer pool. 
4.5.5 Af20279B 
Af20279B was determined as having the best affinity for A. fumigatus and the best specificity, 
with a kd of The aptamer Af202710 showed good levels of affinity and specificity and when 
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analysed under fluorescence microscope showed good binding to A. fumigatus and low levels 
of binding to C. albicans and S. cerevisiae. The fluorescence data is supported by a cell count of 
100 cells, and their fluorescence for each target species, this was repeated twice, and the 
images shown in figure  
4.5.6 Further Testing 
In order to take the testing of these aptamers further a target of each aptamer would need to 
be defined, done by Aptoprecipitation as performed by Aptekhar et al. (2015). This uses the 
isolated aptamer to bind to separated proteins from the target cell. Whichever proteins bind 
can then be characterised and therefor the target determined. 
An important aspect of this study would be to determine kd of the aptamers from this study 
compared to aptamers identified by published literature. Currently in this study there is only 
reference to each of the aptamers for how well each aptamer binds, in order to gain a better 
picture of overall binding, and how well the binding of these aptamers would be used in the 
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